<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<!--
-->
<!-- %html{'xmlns'=>'http://www.w3.org/1999/xhtml', 'xml:lang'=>'en', 'lang'=>'en'} -->
<html>
<head>
<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"beacon-1.newrelic.com","errorBeacon":"jserror.newrelic.com","licenseKey":"d64d3db899","applicationID":"125361","transactionName":"dAkNQBFbXFUEREkBCVQTDlENQB9dDlUTCANZEkxHC1tH","queueTime":0,"applicationTime":2369,"ttGuid":"","agentToken":null,"agent":"js-agent.newrelic.com/nr-298.min.js","extra":""}</script>
<script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function a(b,c,d){function e(f){if(!c[f]){var g=c[f]={exports:{}};b[f][0].call(g.exports,function(a){var c=b[f][1][a];return e(c?c:a)},g,g.exports,a,b,c,d)}return c[f].exports}for(var f=0;f<d.length;f++)e(d[f]);return e}({"4O2Y62":[function(a,b){function c(a,b){var c=d[a];return c?c.apply(this,b):(e[a]||(e[a]=[]),void e[a].push(b))}var d={},e={};b.exports=c,c.queues=e,c.handlers=d},{}],handle:[function(a,b){b.exports=a("4O2Y62")},{}],YLUGVp:[function(a,b){function c(){var a=m.info=NREUM.info,b=m.proto="https"===l.split(":")[0]||a.sslForHttp?"https://":"http://";if(a&&a.agent&&a.licenseKey&&a.applicationID){f("mark",["onload",e()]);var c=h.createElement("script");c.src=b+a.agent,h.body.appendChild(c)}}function d(){"complete"===h.readyState&&f("mark",["domContent",e()])}function e(){return(new Date).getTime()}var f=a("handle"),g=window,h=g.document,i="readystatechange",j="addEventListener",k="attachEvent",l=(""+location).split("?")[0],m=b.exports={offset:e(),origin:l};h[j]?(h[j](i,d,!1),g[j]("load",c,!1)):(h[k]("on"+i,d),g[k]("onload",c)),f("mark",["firstbyte",e()])},{handle:"4O2Y62"}],loader:[function(a,b){b.exports=a("YLUGVp")},{}]},{},["YLUGVp"]);</script>
<title>
Almy v. Sebelius, 679 F.3d 297 (4th Cir. 2012), Court Opinion - Bloomberg Law 

</title>
<meta content='NOINDEX, NOFOLLOW' name='ROBOTS'>
<meta content='telephone=no' name='format-detection'>
<meta content='BLAW' name='apple-mobile-web-app-title'>
<meta name="csrf-param" content="authenticity_token"/>
<meta name="csrf-token" content="NiJ+70&#47;qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA="/>
<script src="/min_assets/framework.js?1389213936" type="text/javascript"></script>

<script src="/javascripts/daterange.js?1380743058" type="text/javascript"></script>
<script src="/javascripts/document/document.js?1382459272" type="text/javascript"></script>
<script src="/javascripts/document/document_viewer.js?1383685414" type="text/javascript"></script>
<script src="/javascripts/document/bciteutils.js?1388683076" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.query.js?1342203941" type="text/javascript"></script>
<script src="/javascripts/browser/browser.js?1387565892" type="text/javascript"></script>
<script src="/javascripts/document/image_viewer.js?1366129555" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.selection.js?1375450295" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.bb-copywithcitation.js?1383771008" type="text/javascript"></script>
<script src="/javascripts/document/copy_with_cite.js?1382560939" type="text/javascript"></script>
<script src="/javascripts/document/notepad.js?1366310522" type="text/javascript"></script>

<link href="/stylesheets/yui2/yui2_combo.css?1288273584" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_v2.css?1391022004" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/min_assets/framework.css?1391022047" media="screen,print" rel="stylesheet" type="text/css" />
<!--[if IE]>
<link href="/stylesheets/ie.css?1391022010" media="screen,print" rel="stylesheet" type="text/css" />
<![endif]-->
<link href="/stylesheets/search/search_results.css?1391022036" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document.css?1391022003" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_viewer.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/search/tree_view.css?1391022037" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/browser/browser_enhanced.css?1391021984" media="print,screen" rel="stylesheet" type="text/css" />
<style type='text/css'>
#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6 { font-family:Times New Roman, Times, serif; }
				#content_document pre {
				white-space: pre-wrap;
				white-space: -moz-pre-wrap;
				white-space: -pre-wrap;
				white-space: -o-pre-wrap;
				word-wrap: break-word;
				font-family: Bloomberg Fixed 2 Unicode;
			}
			
			#content_document .page_no { 
				font-weight:bold;
				text-decoration:none;
			}
			
			#content_document .highlight { 
				font-weight:bold; 
				background-color:yellow; 
				color:black;
			}
			
			#content_document .bcitehi { 
				font-weight:bold; 
				background-color:violet; 
				color:black;
			}
			
			/*.UNICODE {
			}
			
			#content_document blockquote {
			}
			
			#content_document em {
			}   
			
			#content_document .tableofcontents {
			}
			
			#content_document div.blockgroup {
			}
			
			#content_document p.opinion_text {
			}  */
			
			#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6, #content_document p, #content_document li, #content_document td, #content_document th, #content_document div {
				font-size: 11pt;
			}
			
			#content_document .main {
				text-align:center; 
				font-weight:bold; 
				color:black;
			}
			
			#content_document .ftnote { 
				font-style:italic;
			}
			
			#content_document .headline {
				font-weight:bold; 
				color:black;
			} 
			
			#content_document p.group{
				padding-top: 0; 
				padding-bottom: 1px; 
				padding-left: 0; 
				padding-right: 0;
				margin-top: 0; 
				margin-bottom: 1px; 
				margin-left: 0; 
				margin-right: 0;
			}
			
			#content_document .big {
				font-size: 13pt;
			}
			
			#content_document .indent {
				text-indent:2.5em;
			}
			
			#content_document .level2 {
				margin-left:2.5em;
				margin-right:2.5em;
			} 
			
			#content_document .level3 {
				margin-left:5em;
				margin-right:5em;
			} 					
			
			#content_document .level4 {
				margin-left:7.5em;
				margin-right:7.5em;
			} 					
			
			#content_document .level5 {
				margin-left:10em;
				margin-right:10em;
			} 					
			
			#content_document .level6 {
				margin-left:12.5em;
			} 					
			
			#content_document a.sup {
				font-size: 6pt; 
				vertical-align: top;
			}
			
			#content_document a.sup1 {
				font-size: 8pt; 
				vertical-align: top;
			}
			
			#content_document em.italic {
				font-style: italic;
			}
			
			#content_document em.bold {
				font-weight: bold;
				font-style: normal;
			}
			
			#content_document em.bold-big {
				font-size: 13pt; 
				font-weight: bold;
			}
			
			#content_document em.underline {
				font-style:normal; 
				text-decoration: underline;
			}
			
			#content_document em.bold-ital {
				font-weight: bold; 
				font-style: italic;
			}
			
			#content_document em.bold-underline {
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.ital-underline {
				font-style: italic; 
				text-decoration: underline;
			}
			
			#content_document em.ital-bold-underline { 
				font-style: italic; 
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document em.strike {
				font-style: normal;
				text-decoration: line-through;
			}
			
			#content_document .small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document h1.organization {
				font-weight: bold; 
				text-align:center; 
				font-style: normal;
			} 
			
			#content_document h2.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:2.5em; 
				margin-right:2.5em;
			}
			
			#content_document h3.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:5em; 
				margin-right:5em;
			}
			
			#content_document h4.organization {
				font-weight: bold;
				text-align:left;
				margin-left:7.5em; 
				margin-right:5em;
			}
			
			#content_document h5.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:10em; 
				margin-right:5em;
			}
			
			#content_document h2.citation {
				font-weight: bold; 
				text-align:left;
			}
			
			#content_document div.blcitation {
				font-size: 7pt; 
				text-align:center;
			}
			
			#content_document .italic {
				font-style:italic;
			}	
			
			#content_document ul.dash {
				list-style-type: none;
			}
			
			#content_document ul.bullet {
				list-style-type: disc;
			}
			
			#content_document ul.none {
				list-style-type: none;
			}
			
			#content_document li.off {
				list-style-type: none; 
			}
			
			#content_document .mypre { 
				font-size: 100%;
			}
			
			#content_document .TOC {
				text-align:left;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}
			
			#content_document .TOC hr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .bluehr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 500;
				text-align: center;
			}
			
			#content_document .tocentry {
				text-indent:-18px;
				padding-left:18px;
				color: #003399;
				font-weight: 700;
			}
			
			#content_document .doctext {  
				margin:0 auto;  
				text-align: left;  
			}				 
			
			#content_document span.PAGE { 
				color: black; 
				font-weight: bold 
			}
			
			#content_document a:link {  	
				color: #003399;  
				font-weight: 700;
			}
			
			#content_document a:visited {  
				color: #660066;   
				font-weight: 700;
			}
			
			#content_document .fn{  
				padding-left: 50 px; 
				font-weight: 550;
			}				
			
			#content_document .fr a:link {  
				color: #003399;  
				font-weight: 600;
			}
			
			#content_document .fr a:visited {  
				color: #660066;  
				font-weight: 600;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 600;
				text-align: center;
			}
			
			#content_document .volume {  
				text-align:center;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}				
			
			#content_document h2.blcitation {
				font-size: 7pt; 
				text-align:center; 
				white-space:nowrap;
			}
			
			#content_document cite.blcitation {
				white-space:nowrap;
			}
			
			#content_document table.page_legend { 
					width: 100px; 
					text-align: left; 
					background-color: white; 
					font-family: Bloomberg Proportional Unicode;
					font-size: 12px
			}
			#content_document div.page_text {  padding-left: 50 px; margin:0 0 0 50px;  text-align: center;  width:100px; font-size: 12px}

			#content_document .smalllinks{  text-align: right;  font-size: 10px;  font-weight: 500;}		
			
			#content_document .opinion_headnotes{
				margin-top:6px;
				margin-bottom:6px;
			}
			
			#content_document .headnote_group{
				padding: 10px 10px 2px 10px;
				background-color: #ECECEC;
				margin-top:4px;
				margin-bottom:10px;
			}
			
			#content_document .headnote_group_header{
				font-weight: bold;
				margin-bottom: 8px;
			}
			
			#content_document .opinion_headnote{
				clear:both;
				padding-bottom: 4px;
				margin-bottom:10px;
			}
			
			#content_document .highlighted_headnote{
				background-color: #FFFF22;
			}
			
			#content_document .headnote_link{
				font-weight:bold;
				text-decoration: none;
			}
			
			#content_document .show_hide_headnotes{
			}
			
			#content_document .clearfix:after {
				clear:both;
				content: ".";
				height:0px;
				display:block;
				visibility:hidden;
			}
			
			/* BNA Headnotes */
			
			#content_document .headnotesContainer {
				margin: 12px 0;
				padding: 12px 0;
				border-top: 1px solid #000;
				border-bottom: 1px solid #000;
			}
			
			#content_document .headnotesContainer .headnotesContainerTitle {
				font-size: 16px;
				font-weight: bold;
				text-align: center;
			}
			
			#content_document .headnotesContainer .headnoteTitle {
				padding: 8px 12px;
				background-color: #dedede;
				margin: 24px 0 0 0;
				font-size: 16px;
				font-weight: bold;
				text-transform: uppercase;
			}
			
			#content_document .headnotesContainer .headnote {
				margin-left: 24px;
			}
			
			#content_document .headnotesContainer .headnote .headnoteSlug {
				margin-top: 12px;
				font-size: 16px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteDescriptor {
				margin-top: 12px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteToggle .headnoteText {
				margin-bottom: 12px;
			}
		
</style>
<link href="/stylesheets/yui_calendar.css?1391022047" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/docviewer_overrides.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />

<link href="/stylesheets/print.css?1391022029" media="print" rel="stylesheet" type="text/css" />
<link href='/images/favicon.ico' rel='shortcut icon'>
</head>
<body class='securities  document '>
<div class='container'>
<div id='page_loader'></div>
<div class='printHeader printOnly'>
<img src='/images/print_header.jpg'>
<div class='user'>
<span>
Prepared for: Susan Yeh
</span>
</div>
</div>
<div class='topBarHolder printHide'>
<div class='topBar'>
<ul class='topBarElements'>
<li class='skip'>
<a href="#primary_content" tabindex="1">Skip Navigation</a>
</li>
<li class='logout'>
<a href="/log_out.htm" id="logoutButton" onclick="generateExplicitLogoutEvent();">Logout</a>
</li>
<li id='help'>
<a href="/help" target="_blank">Help</a>

</li>
<li id='user'>
<a href="/settings">Susan Yeh</a>

</li>
<li class='withNotifications' id='client_matter'>
<div class='clientMatterDropDown'>
<div>Client Matter</div>
<div class='skinButton blueAlert' style='display:none'>
<span id='currentClientMatter'>

</span>
</div>
<span class='noneSelected' style=''>
&nbsp;(None Selected)
</span>
<div class='expandable'></div>
</div>
<div class='topNavDropdown' id='sub_client_matter'>
<ul>
<li style='display:none'>
<a class='remove_client_matter_menu_item' href='#' onclick='return true;' title='Remove Current Client Matter'>
Remove Current Client Matter
</a>
</li>
<li>
<a class='enter_client_matter_menu_item' href='#' onclick='return true;' title='Enter Client Matter'>
Enter Client Matter
</a>
</li>
</ul>
</div>

</li>
<li class='withNotifications' id='alerts'>
<a href="/alerts/inbox"><div id='unreadAlertsCount'>
Saved Searches & Alerts
</div>
</a>
</li>
<li class='withNotifications' id='downloads'>
<a href="/download/download_center"><div id='unreadDownloadsCount'>
<div>Downloads</div>
</div>
</a>
</li>
<li id='research_trail'>
<a href="/research_trail"><div>Research Trail</div>
</a>
</li>
<li id='workspaces'>
<a href="/workspaces"><div>Workspaces</div>

</a></li>
</ul>
</div>
</div>

<div class='topMenu textBkDark printHide' id='top_menu'>
<div class='contextHolder'>
<a href='/home'>
<h1 class='logo'></h1>
</a>
<div class='menuRow'>
<ul class='menuItems'>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_HOME' onclick="javascript:navigation_selectMenuItem('HOME');">
Home
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button active' id='nav_menu_button_search' onclick="javascript:navigation_selectMenuItem('search');">
Search & Browse
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_practice_areas' onclick="javascript:navigation_selectMenuItem('practice_areas');">
Practice Centers
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LITIGATION' onclick="javascript:navigation_selectMenuItem('LITIGATION');">
Litigation & Dockets
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_transactional' onclick="javascript:navigation_selectMenuItem('transactional');">
Transactional Law
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LEG_REG' onclick="javascript:navigation_selectMenuItem('LEG_REG');">
Legislative & Regulatory
</a>
</li>
<li class='legalAnalysis' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_news' onclick="javascript:navigation_selectMenuItem('news');">
Legal Analysis & News
</a>
</li>
<li class='last' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_market' onclick="javascript:navigation_selectMenuItem('market');">
Companies & Markets
</a>
</li>

</ul>
</div>
<form accept-charset="UTF-8" action="/autocomplete/jump" id="search_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id='quicksearch_context' name='context_value' type='hidden' value='PRACTICE'>
<div class='searchBox' id='quick_search'>
<div class='inputContainer'>
<input autocomplete='off' id='quick_search_term' name='term' onkeydown='framework_handleTextInput(event,quick_search_term)' tabindex='2' type='text'>
<div class='searchButton' onmouseup='return framework_activateForm();' tabindex='3'></div>
<a href="/help/BLAWHelpSystem.htm#GO_Using_the_GO_BAR.htm" class="infoBtn" target="_blank" title="Using the &lt;GO&gt; Bar"></a>
<input id='quick_search_post' name='qs_type' type='hidden' value='general'>
<input id='quick_search_type' name='type' type='hidden' value='input_terms'>
<input id='quick_search_value' name='item_value' type='hidden'>
<input id='quick_search_origin' name='search_type' type='hidden' value='LAW'>
</div>
</div>
</form>


</div>
</div>

<div class='main clearfix'>
<div class='menuDrawer'>
<div class='interior'>
<div class='drawer_shade drawerShade clearfix'>
<div class='dropShadow'></div>
<div class='sub_menu subMenu' id='sub_menu_HOME'>
<table>
<tr>
<td class=''>
<ul>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_search'>
<div class='subTitles'>
<div class='subItem one '>
Search
</div>
<div class='subItem two '>
Specialized Searches
</div>
<div class='subItem one last'>
Browse
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/legal_search'>
<div class='navLinkTitle'>
All Legal Content
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Court Opinions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dnds_search'>
<div class='navLinkTitle'>
Domain Name Decisions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
News
</div>
</a>
</li>
<li>
<a class='clearfix' href='/patent_search'>
<div class='navLinkTitle'>
Patents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/people_search'>
<div class='navLinkTitle'>
People
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Regulatory
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/no_action_search'>
<div class='navLinkTitle'>
SEC No-Action Letters
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.293113'>
<div class='navLinkTitle'>
Federal Law
</div>
</a>
</li>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Law
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_practice_areas'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/antitrust'>
<div class='navLinkTitle'>
Antitrust
</div>
</a>
</li>
<li>
<a class='clearfix' href='/banking_finance'>
<div class='navLinkTitle'>
Banking & Finance
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/bankruptcy'>
<div class='navLinkTitle'>
Bankruptcy
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/corporate_ma'>
<div class='navLinkTitle'>
Corporate/M&A
</div>
</a>
</li>
<li>
<a class='clearfix' href='/employee_benefits'>
<div class='navLinkTitle'>
Employee Benefits
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/health'>
<div class='navLinkTitle'>
Health
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/ip_law'>
<div class='navLinkTitle'>
Intellectual Property
</div>
</a>
</li>
<li>
<a class='clearfix' href='/labor_employment'>
<div class='navLinkTitle'>
Labor & Employment
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/securities'>
<div class='navLinkTitle'>
Securities
</div>
</a>
</li>
<li>
<a class='clearfix' href='/tax'>
<div class='navLinkTitle'>
Tax
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LITIGATION'>
<div class='subTitles'>
<div class='subItem two '>
Litigation
</div>
<div class='subItem two last'>
Dockets
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Search Court Opinions
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_menu/X7TO28O'>
<div class='navLinkTitle'>
BNA Outlines & Headnotes
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.103000'>
<div class='navLinkTitle'>
Federal Rules
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/general'>
<div class='navLinkTitle'>
Litigation Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Search Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/breaking'>
<div class='navLinkTitle'>
Breaking Complaints
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/analytics'>
<div class='navLinkTitle'>
Docket Analytics
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dockets/coverage'>
<div class='navLinkTitle'>
Docket Coverage
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/requests'>
<div class='navLinkTitle'>
Docket Requests
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/tracking'>
<div class='navLinkTitle'>
Docket Tracking
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_transactional'>
<div class='subTitles'>
<div class='subItem two '>
Search
</div>
<div class='subItem two last'>
Resources
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/example_and_saved_searches'>
<div class='navLinkTitle'>
Example Searches
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dealmaker_clause_search'>
<div class='navLinkTitle'>
DealMaker Clauses
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/deal_maker/current_awareness'>
<div class='navLinkTitle'>
Current Awareness
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_menu/X7TS80O'>
<div class='navLinkTitle'>
Drafting Guides & Overviews
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_menu/X7TVS0O'>
<div class='navLinkTitle'>
Transactional Legal Treatises
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/deal_maker/resources'>
<div class='navLinkTitle'>
Transactional Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LEG_REG'>
<div class='subTitles'>
<div class='subItem two '>
Legislative
</div>
<div class='subItem two last'>
Regulatory
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Search Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/leg_search/congressional_bill_search'>
<div class='navLinkTitle'>
Search Congressional Bills
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24221'>
<div class='navLinkTitle'>
U.S. Code
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Legislative Materials
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/leg_news_analysis'>
<div class='navLinkTitle'>
Legislative Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Search Regulatory
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search/federal_register_search'>
<div class='navLinkTitle'>
Search Federal Register
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24230'>
<div class='navLinkTitle'>
Code of Federal Regulations
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Regulatory Materials
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_updates'>
<div class='navLinkTitle'>
Monitor Regulators
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/reg_news_analysis'>
<div class='navLinkTitle'>
Regulatory Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_news'>
<div class='subTitles'>
<div class='subItem two '>
Legal Analysis
</div>
<div class='subItem two last'>
News
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
Search News
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/news'>
<div class='navLinkTitle'>
Legal News
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/news/topic'>
<div class='navLinkTitle'>
News by Topic
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/top_news'>
<div class='navLinkTitle'>
TOP News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_market'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/business_development'>
<div class='navLinkTitle'>
Business Development Center
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
Search EDGAR
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company'>
<div class='navLinkTitle'>
Company Watchlist
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li class='last'>
<a class='clearfix' href='/report_writer'>
<div class='navLinkTitle'>
Company Report Writer
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/market'>
<div class='navLinkTitle'>
Market News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>

</div>
</div>
<div class='bottomFlange'></div>
</div>
<div class='breadcrumbContainer printHide'>
<div class='breadHolder'>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_0'>
Search & Browse
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_1'>
<a href='/conversion/resolve_search/be4d227409bb86f049aee2c7adec6f3b'>
Court Opinions
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_2'>
<a href='/opinion_search/results/be4d227409bb86f049aee2c7adec6f3b'>
Search Results
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
</div>
</div>

</div>
<div class='page clearfix'>
<div class='content' id='page_content'>
<div id='statusHolder'></div>
<a name='primary_content'></a>

<div class='breadCrumbTitleRow clearfix eight grid'>
<div class="icon citation positive" title="Positive"></div>
<div class='title left' title='Almy v. Sebelius, 679 F.3d 297 (4th Cir. 2012), Court Opinion'>
Almy v. Sebelius, 679 F.3d 297 (4th Cir. 2012), Court Opinion
</div>
</div>

<div class='metadata' style='display: none'>
<div class='documentTitle'>Almy v. Sebelius, 679 F.3d 297 (4th Cir. 2012), Court Opinion</div>
<div class='docId'>X1HK8FA003</div>
<div class='docType'>OPINIONS</div>
<div class='case_name'>Almy v. Sebelius</div>
<div class='displayCitation'>2012 BL 102107</div>
<div class='displayCitation'>679 F.3d 297</div>
<div class='displayCitation'>bna a0d1t2t1p3</div>
<div class='displayCitation'>wkf4case:26022133</div>
</div>

<div class='search_outline_node_popup' style='display:none'>
<form accept-charset="UTF-8" action="/document/class_outline_search" id="search_document_node_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>Search</h2>
</div>
<p class='searchOver'>
Search over:
<span class='search_target_node'></span>
<input class="search_source_id" id="source_id" name="source_id" type="hidden" />
<input class="search_node_id" id="search_node_id" name="search_node_id" type="hidden" />
<input class="search_service_code" id="search_service_code" name="search_service_code" type="hidden" />
<input class="search_division" id="search_division" name="search_division" type="hidden" />
<input autocomplete="off" class="search_node_text" id="search_term" name="search_term" type="text" />
</p>
<div class='clearfix'></div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right print' onclick='this.form.submit();'>
<span>
Search
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

</div>
<div id='no_matching_keywords_popup' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>No Matches Found</h2>
</div>
<p>
Search term(s) not found.
</p>
<div class='popUpActions'>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>
<div id='copyWithCitationPopupContents' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>Copy with Citation</h2>
</div>
<p>
Copy the text below to paste into your document.
</p>
<div class='clearfix'>
<div class='copyWithCitationScrollBox'>
<div class='copyWithCitationArea left'>
<div class='copyWithCitationText'></div>
<div class='copyWithCitationDocumentTitle'></div>
</div>
<div class='ie9compat left'>
<img alt="" src="/images/transparency.png?1296705112" width="1" />
</div>
</div>
</div>
<div class='copyWithCitationCheckBoxHolder'>
<input checked="checked" class="linkCitation" id="link_citation" name="link_citation" onclick="updateCopyWithCitationLinks()" type="checkbox" value="true" />
Link citations to Bloomberg Law
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>

<script type='text/javascript'>
  //<![CDATA[
    $('#page_content').addClass("invisible");
  //]]>
</script>
<input id="doc_id" name="doc_id" type="hidden" value="X1HK8FA003" />
<input id="hidden_document_title" name="hidden_document_title" type="hidden" value="Almy v. Sebelius, 679 F.3d 297 (4th Cir. 2012), Court Opinion" />
<input id="hidden_case_name" name="hidden_case_name" type="hidden" value="Almy v. Sebelius" />
<input id="hidden_case_docket" name="hidden_case_docket" type="hidden" />
<div class='toolHolder'>
<form accept-charset="UTF-8" action="" id="downloadPopupLinkForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div><input id="pde_location_type" name="pde_location_type" type="hidden" value="DOCUMENT" /><input id="full_doc_path" name="full_doc_path" type="hidden" value="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X1HK8FA003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="document_type" name="document_type" type="hidden" value="OPINIONS" /><input id="doc_id" name="doc_id" type="hidden" value="X1HK8FA003&amp;search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="artifact_id" name="artifact_id" type="hidden" value="X1HK8FA003" /><input id="title" name="title" type="hidden" value="Almy v. Sebelius, 679 F.3d 297 (4th Cir. 2012), Court Opinion" /><input id="search32" name="search32" type="hidden" value="DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="citation_analysis" name="citation_analysis" type="hidden" value="POSITIVE" /><input id="context_resource_id" name="context_resource_id" type="hidden" value="be4d227409bb86f049aee2c7adec6f3b" /><input id="has_sidebar_info" name="has_sidebar_info" type="hidden" value="true" /><input id="tab_types_" name="tab_types[]" type="hidden" value="TAB_OPINION" /><input id="has_notepad" name="has_notepad" type="hidden" value="true" /><input id="notepad_id" name="notepad_id" type="hidden" value="X1HK8FA003" /><input id="has_headnotes" name="has_headnotes" type="hidden" value="false" /><input id="preselect_option" name="preselect_option" type="hidden" value="DOCUMENT" /></form>

<ul class='tools printHide'>
<li>
<a href="#" onclick="javascript:quickPrintLink(); return false;">Quick Print</a>

</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('download','downloadPopupLinkForm'); return false;">Print/Download</a>
</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('email','downloadPopupLinkForm'); return false;">Email</a>
</li>
<li>
<a href="#" onclick="javascript:addPopupForm('add_to_workspace','?resource_path=%2Fs%2Fopinion%2Fbe%34d%32%32%37%34%30%39bb%38%36f%30%34%39aee%32c%37adec%36f%33b%2Fdocument%2FX%31HK%38FA%30%30%33%3Fsearch%33%32%3DDPNLUQBDE%31FN%30Q%33IC%35PMASPT%36%34TJMSRPDPNMSUBDECUJ%32&amp;document_type=OPINIONS', null); return false;">+ Workspace</a>
</li>
<li>
<a onclick='javascript:PDETray_default.addSelection();'>
+ Queue
</a>
</li>
<li class='last'></li>
</ul>
</div>

<div class='bootstrap printHide tabs'>
<a class='borderTab activeTab' id='tab_DOCUMENT'>
Document
</a>

<a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/bcite/X1HK8FA003/history" class="borderTab inactiveTab" id="tab_HISTORY" onclick="docTabSpinner()">Direct History</a>

<a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/bcite/X1HK8FA003/analysis" class="borderTab inactiveTab" id="tab_ANALYSIS" onclick="docTabSpinner()">Case Analysis</a>

<a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/bcite/X1HK8FA003/toa" class="borderTab inactiveTab" id="tab_TOA" onclick="docTabSpinner()">Table of Authorities</a>

<a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/related_content/X1HK8FA003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="borderTab inactiveTab" id="tab_CITING_DOCS" onclick="docTabSpinner()">Citing Documents</a>

<div class='showHide printHide'>
<div class='showHideSidebarArrow'>
<a class='bliderText' id='bliderLink'>
<span id='bliderText'>
Hide General Info & Notepad
</span>
<span id='notepadCountLabel'></span>
</a>
</div>
</div>

</div>

<!-- document -->
<script type='text/javascript'>
  //<![CDATA[
    var fluid_layout=false;
  //]]>
</script>

<!-- %table.markupContainment -->
<!-- %tbody -->
<!-- %tr -->
<!-- %td#markup_holder{:valign=>"top", :align=>"left"} -->
<div class='docHolder legal hasSearchTerms ' id='doc_holder'>
<div class='documentContent ' id='content_document'>


<script type="text/javascript">
					function Blaw__Citator()
					{
						window.location="bloomberg:bcite_url_prefix=/rest/documents/1705386508291";
					}
				</script><script type="text/javascript">
      var BLAW_TOTAL_KEYWORD = 0;
      var BLAW_CURRENT_KEYWORD = -1;
      var BLAW_LAST_COLOR = "yellow";
      var BLAW_ANCHOR_NAME = "blawkeyword";
      var BLAW_BASE_URL = document.location.href;

      function Blaw__changeCurElem(lastAnchor, newAnchor)
      {
        var baseUrl = Blaw__getBaseURL(document.location.href);
        document.location.href = baseUrl + "#" + newAnchor;
        var elem = document.getElementById(lastAnchor)[0];
        if (elem) {
          elem.style.backgroundColor = BLAW_LAST_COLOR;
        }
        elem = document.getElementById(newAnchor)[0];
        if (elem) {
          BLAW_LAST_COLOR = elem.style.backgroundColor;
          elem.style.backgroundColor = "orange";
        }
      }

      function Blaw__findNextKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (++BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }

        // if index does not exist on page continue to inc until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD < BLAW_TOTAL_KEYWORD) {
            ++BLAW_CURRENT_KEYWORD;
            // wrap around search, once only
            if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD && !looped) {
              BLAW_CURRENT_KEYWORD = 0;
              looped = true;
            }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findPrevKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (--BLAW_CURRENT_KEYWORD < 0) {
          BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
          looped = true;
        }

        // if index does not exist on page continue to decr until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD >= 0) {
          --BLAW_CURRENT_KEYWORD;
          // wrap around search, once only
          if (BLAW_CURRENT_KEYWORD < 0 && !looped) {
            BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
            looped = true;
          }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findNextFrom(indx)
      {
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        BLAW_CURRENT_KEYWORD = indx;
        ++BLAW_CURRENT_KEYWORD;
        if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__getBaseURL(url)
      {
        var reg = new RegExp("(.+)#.+$");
        var ar = reg.exec(url);
        if (ar != null) {
          return ar[1];
        } else {
          return url;
        }
      }


    </script><div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="metadata" style="display: none">
<div class="pagination_series_list">PrimaryFederalReporter,Bloomberg,</div>
<div class="citation-group">
<div class="cite" data-cite-type="PrimaryFederalReporter">679 F.3d 297</div>
<div class="cite" data-cite-type="DocketNumber">10-2241</div>
<div class="cite" data-cite-type="Bloomberg">2012 BL 102107</div>
</div>
</div>
<div align="left" class="tableofcontents">
<br CLEAR="right"><div class="page_text" style="float:right">
<b>Pagination</b><table class="page_legend" cellspacing="0">
<tr>
<td width="25%" align="left" valign="top">*</td>
<td width="50%" align="left" valign="top">F.3d </td>
</tr>
<tr>
<td width="25%" align="left" valign="top">**</td>
<td width="50%" align="left" valign="top">BL</td>
</tr>
</table>
</div>
<br>
</div>
<table><tbody><tr><td>&nbsp;</td></tr></tbody></table>
<p><center>
United States Court of Appeals, Fourth Circuit.
</center></p>
<hr align="center" width="65%">
<p><center>
Monique D. ALMY, Chapter 7 Trustee for the Bankruptcy Estate of BioniCare
Medical Technologies, Incorporated, Plaintiff-Appellant, v. Kathleen
SEBELIUS, in her official capacity as Secretary, United States Department of
Health and Human Services, Defendant-Appellee.
</center></p>
<hr align="center" width="65%">
<p><center>
No. 10-2241.
</center></p>
<p><center>
Argued: January 26, 2012.
</center></p>
<p><center>
Decided: April 26, 2012.
</center></p>
<span CLASS="page_no" data-cite="679 f 3d 298" data-cite-type="PrimaryFederalReporter" data-cite-pageno="298" data-primary-citation="679 F.3d 297">[*298]</span> <div id="para2" printdualcolumn="true"><p>
Appeal from the United States District Court for the District of Maryland,
Richard D. Bennett, J.
<span CLASS="page_no" data-cite="679 f 3d 299" data-cite-type="PrimaryFederalReporter" data-cite-pageno="299" data-primary-citation="679 F.3d 297">[*299]</span> 
</p></div>
<div id="para2" printdualcolumn="true"><p>
<b>ARGUED:</b> Robert Lloyd Roth, Hooper, Lundy &amp; Bookman, PC, Washington, D.C.,
for Appellant. Michael Raab, United States Department of Justice,
Washington, D.C., for Appellee. <b>ON BRIEF:</b> Matthew W. Cheney, Crowell &amp;
Moring LLP, Washington, D.C., for Appellant. William B. Schultz, Acting
General Counsel, Janice L. Hoffman, Associate General Counsel, Mark D.
Polston, Deputy Associate General Counsel for Litigation, Brett Bierer,
Janet Freeman, Gerard Keating, Department of Health &amp; Human Services,
Washington, D.C.; Tony West, Assistant Attorney General, Irene M. Solet,
United States Department of Justice, Washington, D.C.; Rod J. Rosenstein,
United States Attorney, Larry D. Adams, Assistant United States Attorney,
Office of the United States Attorney, Baltimore, Maryland, for Appellee.
</p></div>
<div id="para2" printdualcolumn="true"><p>
Before WILKINSON, GREGORY, and KEENAN, Circuit Judges.
</p></div>
<div id="contentOpinion" printdualcolumn="true"><div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>OPINION</b>
</p></div></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  WILKINSON, Circuit Judge:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Affirmed by published opinion. Judge WILKINSON wrote the opinion, in which
Judge GREGORY and Judge KEENAN joined.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Medicare Part B is a federal program that, among other things, subsidizes
items of durable medical equipment for qualified recipients. Plaintiff
Monique D. Almy, the Chapter 7 trustee for the bankruptcy estate of
BioniCare Medical Technologies, Inc., contests determinations of the
Medicare Appeals Council (MAC) refusing to provide coverage for the
BIO-1000, a device to treat osteoarthritis of the knee. Almy alleges that
the Secretary of Health and Human Services improperly used the adjudicative
process to create a policy of denying coverage for the BIO-1000, that the
MAC's decisions were not supported by substantial evidence, and that the
MAC's decisions were arbitrary and capricious on account of a variety of
procedural errors. We reject those contentions and affirm the judgment of
the district court.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  I.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  A.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Medicare is a federal program providing subsidized health insurance for
the aged and disabled. <i>See</i><a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XEJAHQ003?jcsearch=42%20usc%201395&amp;summary=yes#jcite">42 U.S.C. &sect; 1395</a><i>et seq.</i> The Secretary of Health
and Human Services ("the Secretary"), Kathleen Sebelius, is charged by
Congress with administering the Medicare statute. <i><cite>Id</cite>.</i> <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XEJALO003?jcsearch=42%20U.S.C.%20%201395ff(a)(1)&amp;summary=yes#jcite">&sect; 1395ff(a)(1)</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Part B of the Medicare Act extends coverage to certain types of durable
medical equipment (DME) for qualified recipients. <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XEJAJG003?jcsearch=42%20U.S.C.%20%201395k(a)&amp;summary=yes#jcite">42 U.S.C. &sect; 1395k</a>(a); <i><cite>id</cite>.</i>
<a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XEJAL8003?jcsearch=42%20U.S.C.%20%201395x(s)(6)&amp;summary=yes#jcite">&sect; 1395x(s)(6)</a>. Not all DME is guaranteed coverage under Medicare Part B,
however. The Medicare statute explicitly provides that "no payment may be
made under . . . Part B of this subchapter for any expenses incurred for
items . . . [which] are not reasonable and necessary for the diagnosis or
treatment of illness or injury or to improve the functioning of a malformed
body member." <i><cite>Id</cite>.</i> <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XEJALA003?jcsearch=42%20U.S.C.%20%201395y(a)(1)(A)&amp;summary=yes#jcite">&sect; 1395y(a)(1)(A)</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Acting through her operating components, the Secretary <span CLASS="page_no" data-cite="2012 bl 102107 p 2" data-cite-type="Bloomberg" data-cite-pageno="2" data-primary-citation="">[**2]</span> can elect to
determine the coverage of DME in one of three ways. First, she can make a
"national coverage determination" (NCD) binding throughout the Medicare
system and not subject to review by administrative law judges. <i><cite>Id</cite>.</i> <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XEJALO003?jcsearch=42%20U.S.C.%20%201395ff(f)(1)(B)&amp;summary=yes#jcite">&sect;
1395ff(f)(1)(B)</a>. Second, one of the private insurance carriers with whom the
Secretary contracts to administer claims under Part B, <i>see <cite>id</cite>.</i> <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XEJAK6003?jcsearch=42%20U.S.C.%20%201395u(a)&amp;summary=yes#jcite">&sect; 1395u(a)</a>,
can issue a "local coverage determination" (LCD) "respecting whether or not
a particular item or service is covered on an intermediary- or carrier-wide
basis." <i><cite>Id</cite>.</i>
<span CLASS="page_no" data-cite="679 f 3d 300" data-cite-type="PrimaryFederalReporter" data-cite-pageno="300" data-primary-citation="679 F.3d 297">[*300]</span> 
<a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XEJALO003?jcsearch=42%20U.S.C.%20%201395ff(f)(2)(B)&amp;summary=yes#jcite">&sect; 1395ff(f)(2)(B)</a>. Finally, if no NCD or LCD is in place, "contractors may
make individual claim determinations," including whether a particular DME
meets the statutory requirement of being "reasonable and necessary."
<a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/1?citation=68%20Fed.Reg.%2063&amp;summary=yes#jcite">68 Fed.Reg. 63</a>,693.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Secretary has also developed guidance in the Medicare Program
Integrity Manual (MPIM) for Medicare contractors applying the "reasonable
and necessary" standard. Rather than create distinct criteria for individual
claim determinations and LCDs, the Secretary has directed contractors to
apply a uniform set of standards, providing that "[w]hen making individual
claim determinations, . . . [a] service may be covered by a contractor if it
meets all of the conditions listed in [MPIM] &sect; [1]3.5.1, Reasonable and
Necessary Provisions in LCDs below."<a HREF="#fn100" name="fnref_fn100">[fn1]</a> MPIM <cite>&sect; 13.3</cite>, Individual Claim
Determinations. For a device to be considered "reasonable and necessary,"
contractors must determine that the item is "safe and effective; not
experimental or investigational . . .; and appropriate" in terms of both
"accepted medical practice" and "the patient's medical need." MPIM <cite>&sect; 13.5.1</cite>,
Reasonable and Necessary Provisions in LCDs.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Secretary has also instructed contractors as to the type of evidence
to be used in making these technical determinations. Such decisions should
be based on either "published authoritative evidence" such as "definitive
randomized clinical trials" or "general acceptance by the medical
community," with the caveat that "[a]cceptance by individual health care
providers" and "limited case studies distributed by sponsors with a
financial interest in the outcome[] are not sufficient evidence of general
acceptance by the medical community." MPIM <cite>&sect; 13.7.1</cite>, Evidence Supporting
LCDs.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Medicare statute and accompanying regulations create a five-step
appeals process for claimants dissatisfied with the initial determination of
the Medicare contractor. First, the party can seek redetermination from the
initial contractor. <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XEJALO003?jcsearch=42%20U.S.C.%20%201395ff(b)(1)(A)&amp;summary=yes#jcite">42 U.S.C. &sect; 1395ff</a>(b)(1)(A). Second, the claimant can
seek "re-consideration" of the contractor's determinations by a "qualified
independent contractor" (QIC). <i><cite>Id</cite>.</i> <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XEJALO003?jcsearch=42%20U.S.C.%20%201395ff(c)&amp;summary=yes#jcite">&sect; 1395ff(c)</a>. If no applicable NCD or LCD
governs claims for a particular device, the QIC is instructed by statute to
"make a decision with respect to the reconsideration based on applicable
information, including clinical experience and medical, technical, and
scientific evidence." <i><cite>Id</cite>.</i> <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XEJALO003?jcsearch=42%20U.S.C.%20%201395ff(c)(3)(B)(ii)(III)&amp;summary=yes#jcite">&sect; 1395ff(c)(3)(B)(ii)(III)</a>. Third, a claimant can
request "a hearing on a decision of a qualified independent contractor"
before an administrative law judge. <i><cite>Id</cite>.</i> <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XEJALO003?jcsearch=42%20U.S.C.%20%201395ff(d)(1)&amp;summary=yes#jcite">&sect; 1395ff(d)(1)</a>. Fourth, a party's
final administrative appeal within the Department of Health and Human
Services is to the Medicare <span CLASS="page_no" data-cite="2012 bl 102107 p 3" data-cite-type="Bloomberg" data-cite-pageno="3" data-primary-citation="">[**3]</span> Appeals Council (MAC), a part of the
Departmental Appeals Board. <i><cite>Id</cite>.</i> <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XEJALO003?jcsearch=42%20U.S.C.%20%201395ff(d)(2)&amp;summary=yes#jcite">&sect; 1935ff(d)(2)</a>. The statute specifically
provides that "the Departmental Appeals Board shall review the case de
novo." <i><cite>Id</cite>.</i> <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XEJALO003?jcsearch=42%20U.S.C.%20%201395ff(d)(2)(B)&amp;summary=yes#jcite">&sect; 1395ff(d)(2)(B)</a>. Lastly, a party can bring a civil action in
federal court to review a final decision of the Secretary (through the
Medicare Appeals Council). <i><cite>Id</cite>.</i> <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XEJALO003?jcsearch=42%20U.S.C.%20%201395ff(b)(1)(A)&amp;summary=yes#jcite">&sect; 1395ff(b)(1)(A)</a>; <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X197B84003?jcsearch=42%20U.S.C.%20%20405(g)&amp;summary=yes#jcite">&sect; 405(g)</a>. The statute
there prescribes that the Secretary's findings, "if supported by substantial
evidence, shall be conclusive" in the judicial proceeding. <i><cite>Id</cite>.</i> <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X197B84003?jcsearch=42%20U.S.C.%20%20405(g)&amp;summary=yes#jcite">&sect; 405(g)</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  B.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The DME at issue in this case is the BioniCare Stimulator System, Model
1000 (BIO-1000), a
<span CLASS="page_no" data-cite="679 f 3d 301" data-cite-type="PrimaryFederalReporter" data-cite-pageno="301" data-primary-citation="679 F.3d 297">[*301]</span> 
medical device used to treat osteoarthritis of the knee by delivering
electrical pulses to the joint. The device was originally developed by
Murray Electronics, which sought approval from the Food and Drug
Administration (FDA) under the Federal Food, Drug, and Cosmetic Act to
market the device. The BIO-1000 was originally submitted for "Pre-Market
Approval" (PMA), the most stringent review under the Act, which requires
sophisticated proof of the safety and effectiveness of the device.
<i>See</i><a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XEI5PI003?jcsearch=21%20usc%20360c&amp;summary=yes#jcite">21 U.S.C. &sect; 360c</a><i>el seq.</i> In 1997, however, Murray Electronics notified the
FDA of its intent to market the BIO-1000 pursuant to a less-rigorous
provision of the statute, known as the "510(k) process."
<i>See</i><a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XEI5PI003?jcsearch=21%20U.S.C.%20%20360c(f)(1)(A)(ii)&amp;summary=yes#jcite">21 U.S.C. &sect; 360c</a>(f)(1)(A)(ii).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XUQM9I003?jcsearch=21%20C.F.R.%20Part%20510&amp;summary=yes#jcite">Section 510(k)</a> allows a device to be marketed based not on independent
clinical trials of the device itself, but instead because the device is
"substantially equivalent to another device" that is already on the market.
<i><a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XUQM9I003?jcsearch=21%20C.F.R.%20Part%20510&amp;summary=yes#jcite">Id</a>.</i> FDA regulations require that for a device to receive 510(k) approval,
the device must have "the same intended use as the predicate device" and the
sponsor must "demonstrate[] that the device is as safe and as effective as a
legally marketed device." <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XMJ998003?jcsearch=21%20C.F.R.%20%20807.100(b)(ii)(B)&amp;summary=yes#jcite">21 C.F.R. &sect; 807.100</a>(b)(ii)(B). In July 1997, the
FDA issued approval under 510(k) for the BIO-1000 to be marketed, finding
that it was substantially equivalent to the Transcutaneous Electric Nerve
Stimulator (TENS) device that was already on the market.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Since that time, BioniCare has distributed the BIO-1000 to thousands of
patients and submitted numerous Medicare claims. While some contractors have
provided Medicare coverage for the BIO-1000, others have frequently refused
to cover the device. At issue in this appeal are eight groups of claims
denying coverage, which were appealed through the entire administrative
process to the MAC. In seven of those cases, the Secretary, through the MAC,
determined that the BIO-1000 was not "reasonable and necessary" and was
therefore excluded from the statutory coverage of Medicare Part B. All seven
cases relied on BioniCare's failure to provide evidence in accordance with
MPIM <cite>&sect; 13.7.1</cite> that demonstrated that the device was "safe and effective."
Appellant's Br. at 21-27 (describing the 535, 310, 208, 891, 852, 259, and
781 Decisions). In the eighth case, BioniCare did not appeal the ALJ's
determination that the device was "reasonable and necessary," and so the MAC
did not address that question. Instead, the MAC merely affirmed a payment
calculation based on a local fee schedule that was unfavorable to
Bioni-Care. Appellant's Br. at 27-28 (describing 191 Decision).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Plaintiff Monique D. Almy, <span CLASS="page_no" data-cite="2012 bl 102107 p 4" data-cite-type="Bloomberg" data-cite-pageno="4" data-primary-citation="">[**4]</span> the Chapter 7 trustee for the bankruptcy estate
of BioniCare, filed this lawsuit in May 2008, seeking a reversal of the MAC
decisions. Both Almy and the Secretary moved for summary judgment, and on
September 3, 2010, the district court granted the Secretary's motion in
full. This appeal followed.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  II.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  A brief discussion of the standard of review of the Secretary's decision
is necessary at the outset.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  A.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  With respect to factual determinations, the Medicare statute specifies
that "the findings of the [Secretary] as to any fact, if supported by
substantial evidence, shall be conclusive." <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X197B84003?jcsearch=42%20U.S.C.%20%20405(g)&amp;summary=yes#jcite">42 U.S.C. &sect; 405</a>(g). The Supreme
Court has defined substantial evidence as "more than a mere scintilla. It
means such relevant evidence as a reasonable mind might accept as adequate
to support a conclusion." <i>Consolidated Edison</i>
<span CLASS="page_no" data-cite="679 f 3d 302" data-cite-type="PrimaryFederalReporter" data-cite-pageno="302" data-primary-citation="679 F.3d 297">[*302]</span> 
<i>Co. v. NLRB</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5BVRN?jcsearch=305%20us%20197&amp;summary=yes#jcite">305 U.S. 197</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5BVRN?jcsearch=305%20us%20197&amp;summary=yes#jcite">229</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5BVRN?jcsearch=59%20supreme%20court%20206&amp;summary=yes#jcite">59 S.Ct. 206</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5BVRN?jcsearch=83%20l%20ed%20126&amp;summary=yes#jcite">83 L.Ed. 126</a> (1938). Our
review is therefore necessarily a limited one. "[W]e do not undertake to
re-weigh conflicting evidence, make credibility determinations, or
substitute our judgment for that of the Secretary. Where conflicting
evidence allows reasonable minds to differ . . ., the responsibility for
that decision falls on the Secretary." <i>Craig v. Chater</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X3PHEH?jcsearch=76%20f%203d%20585&amp;summary=yes#jcite">76 F.3d 585</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X3PHEH?jcsearch=76%20f%203d%20585&amp;summary=yes#jcite">589</a>
(4th Cir.1996).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Quite apart from matters of fact, the Secretary's decisions are governed
by the Administrative Procedure Act (APA), which requires courts to
determine whether the agency's action was "arbitrary, capricious, an abuse
of discretion, . . . other-wise not in accordance with law, . . . [or]
without observance of procedure required by law." <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XEGP3C003?jcsearch=5%20U.S.C.%20%20706(2)&amp;summary=yes#jcite">5 U.S.C. &sect; 706</a>(2). Our
court has been clear that "[r]eview under this standard is highly
deferential, with a presumption in favor of finding the agency action
valid." <i>Ohio Vail. Envt'l Coalition v. Aracoma Coal Co.</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X1AIQES003?jcsearch=556%20f%203d%20177&amp;summary=yes#jcite">556 F.3d 177</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X1AIQES003?jcsearch=556%20f%203d%20177&amp;summary=yes#jcite">192</a>
(4th Cir.2009). In practice, an action will not be considered arbitrary and
capricious so long as "the agency has examined the relevant data and
provided an explanation of its decision that includes 'a rational connection
between the facts found and the choice made.'" <i></i><a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X1AIQES003?jcsearch=556%20F.3d%20192-93&amp;summary=yes#jcite">Id. at 192-93</a> (quoting <i>Motor</i>
<i>Veh. Mfrs. Ass'n v. State Farm Mut. Ins. Co.</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X2N70F?jcsearch=463%20us%2029&amp;summary=yes#jcite">463 U.S. 29</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X2N70F?jcsearch=463%20us%2029&amp;summary=yes#jcite">43</a>,
<a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X2N70F?jcsearch=103%20supreme%20court%202856&amp;summary=yes#jcite">103 S.Ct. 2856</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X2N70F?jcsearch=77%20l%20ed%202d%20443&amp;summary=yes#jcite">77 L.Ed.2d 443</a> (1983)).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  B.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In addition to these statutory directives, a variety of judicial doctrines
require that courts not casually overturn the Secretary's decisions. First,
it is well recognized that the Secretary's interpretation of what is
"reasonable and necessary" under the Medicare Act is entitled to judicial
deference pursuant to <i>Chevron U.S.A., Inc. v. Natural Res. Def. Council,</i>
<i>Inc.</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CAVA?jcsearch=467%20us%20837&amp;summary=yes#jcite">467 U.S. 837</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CAVA?jcsearch=104%20supreme%20court%202778&amp;summary=yes#jcite">104 S.Ct. 2778</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CAVA?jcsearch=81%20l%20ed%202d%20694&amp;summary=yes#jcite">81 L.Ed.2d 694</a> (1984). "[B]ecause the
Secretary is charged with administering the Medicare Act, we substantially
defer to the Secretary's construction of any ambiguous language in the Act,
if the Secretary's construction 'is based on a permissible construction of
the statute.'" <i>MacKenzie Medical Supply, Inc. v. Leavitt</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X17T6AK003?jcsearch=506%20f%203d%20341&amp;summary=yes#jcite">506 F.3d 341</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X17T6AK003?jcsearch=506%20f%203d%20341&amp;summary=yes#jcite">346</a>
(4th Cir.2007) (quoting <i></i><a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CAVA?jcsearch=467%20U.S.%20837&amp;summary=yes#jcite">id. at 843</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CAVA?jcsearch=104%20supreme%20court%202778&amp;summary=yes#jcite">104 S.Ct. 2778</a>).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Second, the Secretary is also entitled to deference under <i>Bowles v.</i>
<i>Seminole Rock &amp; Sand Co.</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X2N5SO?jcsearch=325%20us%20410&amp;summary=yes#jcite">325 U.S. 410</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X2N5SO?jcsearch=65%20supreme%20court%201215&amp;summary=yes#jcite">65 S.Ct. 1215</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X2N5SO?jcsearch=89%20l%20ed%201700&amp;summary=yes#jcite">89 L.Ed. 1700</a> (1945),
for her interpretation of the regulations that implement the Medicare Act's
"reasonable and necessary" standard. This principle requires courts to give
an agency's view of its own regulations "controlling weight unless it is
plainly erroneous or inconsistent with the <span CLASS="page_no" data-cite="2012 bl 102107 p 5" data-cite-type="Bloomberg" data-cite-pageno="5" data-primary-citation="">[**5]</span> regulation." <i></i><a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X2N5SO?jcsearch=325%20U.S.%20410&amp;summary=yes#jcite">Id. at 414</a>,
<a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X2N5SO?jcsearch=65%20supreme%20court%201215&amp;summary=yes#jcite">65 S.Ct. 1215</a>. The Supreme Court has emphasized the importance of careful
adherence to this standard in the Medicare context, which deals with "a
complex and highly technical regulatory program, in which the identification
and classification of relevant criteria necessarily require significant
expertise and entail the exercise of judgment grounded in policy concerns."
<i>Th. Jefferson Univ. v. Shalala</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CCJ7?jcsearch=512%20us%20504&amp;summary=yes#jcite">512 U.S. 504</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CCJ7?jcsearch=512%20us%20504&amp;summary=yes#jcite">512</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CCJ7?jcsearch=114%20supreme%20court%202381&amp;summary=yes#jcite">114 S.Ct. 2381</a>,
<a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CCJ7?jcsearch=129%20l%20ed%202d%20405&amp;summary=yes#jcite">129 L.Ed.2d 405</a> (1994)
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Thus the very nature of the Medicare program suggests that the Secretary's
determinations are entitled to deference from this court. The parties agree
that Medicare regulation "is technical and complex" and that the Secretary
"has longstanding expertise in the area," circumstances under which
"principles of deference have particular force." <i>Alum. Co. of Amer. v. Cent.</i>
<i>Lincoln Peoples' Util. Dist.</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CAU4?jcsearch=467%20us%20380&amp;summary=yes#jcite">467 U.S. 380</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CAU4?jcsearch=467%20us%20380&amp;summary=yes#jcite">390</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CAU4?jcsearch=104%20supreme%20court%202472&amp;summary=yes#jcite">104 S.Ct. 2472</a>,
<a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CAU4?jcsearch=81%20l%20ed%202d%20301&amp;summary=yes#jcite">81 L.Ed.2d 301</a> (1984). Because the determination of what is "reasonable and
necessary" also requires
<span CLASS="page_no" data-cite="679 f 3d 303" data-cite-type="PrimaryFederalReporter" data-cite-pageno="303" data-primary-citation="679 F.3d 297">[*303]</span> 
a significant degree of medical judgment, we must be mindful that "[w]hen
examining this kind of scientific determination, as opposed to simple
findings of fact, a reviewing court must generally be at its most
deferential." <i>Bait. Gas &amp; Elec. Co. v. Natural Res. Def. Council, Inc.</i>,
<a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CALG?jcsearch=462%20us%2087&amp;summary=yes#jcite">462 U.S. 87</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CALG?jcsearch=462%20us%2087&amp;summary=yes#jcite">103</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CALG?jcsearch=103%20supreme%20court%202246&amp;summary=yes#jcite">103 S.Ct. 2246</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CALG?jcsearch=76%20l%20ed%202d%20437&amp;summary=yes#jcite">76 L.Ed.2d 437</a> (1983).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  With these limitations in mind, we consider in turn BioniCare's three
challenges to the MAC decisions affirmed by the district court. First,
BioniCare disputes the Secretary's use of the individual adjudication
process at all, arguing that she should instead have issued an NCD or LCD
for the BIO-1000. Second, even if adjudication was the correct process,
BioniCare asserts that the MAC decisions were not supported by substantial
evidence. Finally, BioniCare alleges a variety of procedural errors at the
various rungs of the administrative ladder that it claims infect the MAC's
ultimate decisions.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  III.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  BioniCare contends that because the MAC decisions were based on the safety
and effectiveness of the BIO-1000 generally, rather than the medical
necessity of the device for any particular patient, the Secretary erred by
proceeding through individual adjudications, and she should instead have
issued an NCD or LCD to implement a prospective coverage policy. But
BioniCare ignores directly applicable Supreme Court precedent, which makes
clear that the Secretary enjoys full discretion to choose to proceed by
adjudication rather than by rulemaking.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  One of the earliest principles developed in American administrative law
was the idea that "the choice made between proceeding by general rule or by
individual, <i>ad hoc</i> litigation is one that lies primarily in the informed
discretion of the administrative agency." <i>SEC v. Chenery Corp.</i>,
<a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5C17Q?jcsearch=332%20us%20194&amp;summary=yes#jcite">332 U.S. 194</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5C17Q?jcsearch=332%20us%20194&amp;summary=yes#jcite">203</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5C17Q?jcsearch=67%20supreme%20court%201575&amp;summary=yes#jcite">67 S.Ct. 1575</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5C17Q?jcsearch=91%20l%20ed%201995&amp;summary=yes#jcite">91 L.Ed. 1995</a> (1947). The Medicare statute
preserves this discretion for the Secretary, leaving it to her judgment
whether to proceed by implementing an NCD, by allowing regional contractors
to adopt an LCD, or by deciding individual cases through the adjudicative
process. Indeed, in <i>Heckler v. Ringer</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CATS?jcsearch=466%20us%20602&amp;summary=yes#jcite">466 U.S. 602</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CATS?jcsearch=104%20supreme%20court%202013&amp;summary=yes#jcite">104 S.Ct. 2013</a>,
<a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CATS?jcsearch=80%20l%20ed%202d%20622&amp;summary=yes#jcite">80 L.Ed.2d 622</a> (1984), the Supreme Court expressly foreclosed the argument
that BioniCare now presses, holding that "[t]he Secretary's decision as to
whether <span CLASS="page_no" data-cite="2012 bl 102107 p 6" data-cite-type="Bloomberg" data-cite-pageno="6" data-primary-citation="">[**6]</span> a particular medical service is 'reasonable and necessary' and the
means by which she implements her decision, whether by promulgating a
generally applicable rule or by allowing individual adjudication, are
clearly discretionary decisions." <i></i><a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CATS?jcsearch=466%20U.S.%20602&amp;summary=yes#jcite">Id. at 617</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CATS?jcsearch=104%20supreme%20court%202013&amp;summary=yes#jcite">104 S.Ct. 2013</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Not only does the Secretary have the discretion to choose which route to
take in assessing the Part B coverage for a device, but BioniCare's asserted
concern that the Secretary is "improperly implement[ing] a coverage policy,"
Appellant's Br. at 50, is simply illusory. The Secretary's own regulations
make clear that any policy implications in an adjudication do not have
precedential effect. <i>See, e.g.</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X11MVHC003?jcsearch=42%20cfr%20405%201062&amp;summary=yes#jcite">42 C.F.R. &sect; 405.1062</a> ("If an ALJ or MAC
declines to follow a policy in a particular case, . . . [the] decision to
disregard such policy applies only to the specific claim being considered
and does not have precedential effect"). The purported "policy" in this case
is nothing more than the accretion of individual decisions finding that the
BIO-1000 does not meet the statutory requirements for coverage.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Our court has previously refused to constrict the "flexibility of the
Secretary" in implementing the "reasonable and necessary" standard,
<i>MacKenzie Medical Supply</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X17T6AK003?jcsearch=506%20f%203d%20341&amp;summary=yes#jcite">506 F.3d at 348</a>, but that is precisely
<span CLASS="page_no" data-cite="679 f 3d 304" data-cite-type="PrimaryFederalReporter" data-cite-pageno="304" data-primary-citation="679 F.3d 297">[*304]</span> 
what BioniCare asks us to do. As the district court correctly recognized,
the result of BioniCare's theory would be to "effectively requir[e] the
Secretary to issue item-specific coverage rules for each and every item of
DME before issuing case adjudications." <i>Almy v. Sebelius</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X1E59HU003?jcsearch=749%20f%20supp%202d%20315&amp;summary=yes#jcite">749 F.Supp.2d 315</a>,
<a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X1E59HU003?jcsearch=749%20f%20supp%202d%20315&amp;summary=yes#jcite">324</a> n. 2 (D.Md.2010). But Congress has clearly left it to the discretion of
the Secretary to decide how to deal with hundreds of millions of Part B
claims for coverage of thousands of devices every year. The Medicare Act
"has produced a complex and highly technical regulatory program," the
administration of which turns on "[t]he identification and classification of
medical eligibility criteria [that] necessarily require significant
expertise and entail the exercise of judgment grounded in policy concerns."
<i>Pauley v. BethEnergy Mines, Inc.</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CC36?jcsearch=501%20us%20680&amp;summary=yes#jcite">501 U.S. 680</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CC36?jcsearch=501%20us%20680&amp;summary=yes#jcite">697</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CC36?jcsearch=111%20supreme%20court%202524&amp;summary=yes#jcite">111 S.Ct. 2524</a>,
<a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CC36?jcsearch=115%20l%20ed%202d%20604&amp;summary=yes#jcite">115 L.Ed.2d 604</a> (1991). These are the hallmarks of agency discretion, and
BioniCare points to no statutory text or other legal basis that would allow
the courts to inject themselves into the administration of the Part B claims
process. Congress has not seen fit to set mandatory conditions for the use
of NCDs or LCDs, and we refuse to craft such requirements out of whole
cloth.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Supreme Court has long warned about the unsuitability of precisely the
kind of rule BioniCare urges us to adopt: "To hold that the [Secretary] had
no alternative in this proceeding but to approve the proposed transaction,
while formulating any general rules it might desire for use in future cases
of this nature, would be to stultify the administrative process." <i>Chenery</i>,
<a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5C17Q?jcsearch=332%20us%20194&amp;summary=yes#jcite">332 U.S. at 202</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5C17Q?jcsearch=67%20supreme%20court%201575&amp;summary=yes#jcite">67 S.Ct. 1575</a>. And like the Supreme Court, "[t]hat we
refuse to do." <i><a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5C17Q?jcsearch=332%20U.S.%20at%20202&amp;summary=yes#jcite">Id</a>.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  IV.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  BioniCare's next major claim is that the Secretary's decisions were not
supported by "substantial evidence" as required by both the Medicare statute
and the APA. This allegation comes in three parts. First, BioniCare asserts
that the Secretary <span CLASS="page_no" data-cite="2012 bl 102107 p 7" data-cite-type="Bloomberg" data-cite-pageno="7" data-primary-citation="">[**7]</span> applied the wrong standard in assessing the relevant
evidence. Second, it claims that the Secretary has a heightened burden of
proof. BioniCare asserts that it made a prima facie case for coverage, which
requires the Secretary to produce affirmative evidence in rebuttal in order
for the MAC's denial of coverage to be supported by substantial evidence.
Finally, BioniCare claims that it did in fact produce adequate evidence to
justify coverage of the BIO-1000, and that the MAC's critique of that proof
is inadequate to support a denial of such coverage. We disagree with
BioniCare on all three fronts.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  A.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  BioniCare first contends that the MAC decisions applied the wrong standard
for individual claim determinations, arguing that the MAC erroneously relied
on standards only applicable to LCDs. The Secretary has, however, made clear
that the same criteria that govern LCDs should also govern individual
adjudications. MPIM <cite>&sect; 13.3</cite>, Individual Claim Determinations, specifically
provides that for individual adjudications, contractors should use the
standards set out for LCDs in MPIM <cite>&sect; 13.5.1</cite>. It is that section, entitled
"Reasonable and Necessary Provisions in LCDs," that sets out the substantive
criteria that a device must meet in order to receive coverage. Specifically,
in order to be considered "reasonable and necessary,"
<i>see</i><a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XEJALA003?jcsearch=42%20U.S.C.%20%201395y(a)(1)(A)&amp;summary=yes#jcite">42 U.S.C. &sect; 1395y</a>(a)(1)(A), a device must be "safe and effective; not
experimental or investigational . . .; and appropriate," MPIM <cite>&sect; 13.5.1</cite>, and
BioniCare does not dispute that a device must meet
<span CLASS="page_no" data-cite="679 f 3d 305" data-cite-type="PrimaryFederalReporter" data-cite-pageno="305" data-primary-citation="679 F.3d 297">[*305]</span> 
those requirements in order to receive Part B coverage.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  BioniCare contends, however, that the Secretary erred by using the
guidelines of MPFM <cite>&sect; 13.7.1</cite>, Evidence Supporting LCDs, to evaluate the
studies it offered to show that the BIO-1000 was safe and effective.
BioniCare argues that these standards apply only to LCDs, and not to
individual adjudications. As we have explained, however, the Secretary has
adopted a single set of standards that governs both LCDs and individual
adjudications. The MPFM section on individual adjudications, <cite>&sect; 13.3</cite>,
indisputably incorporates by reference the substantive criteria applicable
to LCDs in <cite>&sect; 13.5.1</cite>, and MPFM <cite>&sect; 13.7.1</cite> does no more than explicate the type
of evidence that may demonstrate a device's compliance with the conjunctive
standards of <cite>&sect; 13.5.1</cite>. Specifically, MPIM <cite>&sect; 13.7.1</cite> requires a claimant to
show that a device is safe and effective through "published authoritative
evidence" such as "definitive randomized clinical trials" or "general
acceptance by the medical community," with the qualification that
"[a]cceptance by individual health care providers" and "limited case studies
distributed by sponsors with a financial interest in the outcome[] are not
sufficient evidence of general acceptance by the medical community." MPIM <cite>&sect;
13.7.1</cite>, Evidence Supporting LCDs. Far from being "arbitrary [or]
capricious," the Secretary has directed contractors to use uniform criteria
in assessing Part B coverage, supported by uniform types of evidence, and it
was not erroneous or inconsistent for the MAC to have applied the
requirements <span CLASS="page_no" data-cite="2012 bl 102107 p 8" data-cite-type="Bloomberg" data-cite-pageno="8" data-primary-citation="">[**8]</span> of MPIM <cite>&sect; 13.7.1</cite>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  B.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Second, BioniCare disputes the appropriate burden of proof that governs a
"reasonable and necessary" determination by the MAC. It claims that, having
made a prima facie case, the burden shifts to the Secretary to rebut that
evidence with her own offer of proof, and that it is insufficient for the
MAC to provide merely a critique of BioniCare's showing. But there is no
basis in law for this assertion. It is well established that "a claimant . .
. has the burden of proving entitlement to Medicare benefits," <i>Friedman v.</i>
<i>Sec'y of Dept. of Health and Hum. Servs.</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XAFI1L?jcsearch=819%20f%202d%2042&amp;summary=yes#jcite">819 F.2d 42</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XAFI1L?jcsearch=819%20f%202d%2042&amp;summary=yes#jcite">45</a> (2d Cir.1987).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Even the case BioniCare cites in support of its conclusion, <i>Dir., Off. of</i>
<i>Workers' Comp. Progs, v. Greenwich Collieries</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CCJ1?jcsearch=512%20us%20267&amp;summary=yes#jcite">512 U.S. 267</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CCJ1?jcsearch=114%20supreme%20court%202251&amp;summary=yes#jcite">114 S.Ct. 2251</a>,
<a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CCJ1?jcsearch=129%20l%20ed%202d%20221&amp;summary=yes#jcite">129 L.Ed.2d 221</a> (1994), does not point to a different result. While it is
doubtful that the standards for formal adjudication at issue in that case
even apply to these informal proceedings under the Medicare Act, the most
that the <i>Greenwich Collieries</i> Court concluded was that "when the party with
the burden of persuasion establishes a prima facie case supported by
'credible and credited evidence,' it must either be rebutted or accepted as
true." <i></i><a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CCJ1?jcsearch=512%20U.S.%20267&amp;summary=yes#jcite">Id. at 280</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CCJ1?jcsearch=114%20supreme%20court%202251&amp;summary=yes#jcite">114 S.Ct. 2251</a>. Here, the MAC'S conclusion was that
BioniCare had failed to satisfy the critical first step, because it did not
provide "credible and credited evidence," as measured against the standards
set out in MPIM <cite>&sect; 13.7.1</cite>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  C.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Using the appropriate standard of review and burden of proof, the
Secretary's determination that BioniCare did not establish that the BIO-1000
was "safe and effective" and "not experimental or investigational" was in
fact supported by substantial evidence. It is not our office to tender an
independent judgment on the value and validity of the various scientific
studies submitted. We ask only whether the Secretary's
<span CLASS="page_no" data-cite="679 f 3d 306" data-cite-type="PrimaryFederalReporter" data-cite-pageno="306" data-primary-citation="679 F.3d 297">[*306]</span> 
assessment was a reasonable one, and we are satisfied that it was.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The MAC reviewed the studies submitted by BioniCare in support of the
BIO-1000 and identified numerous deficiencies that deprived them of
persuasive value. BioniCare submitted twenty-one separate studies. Five of
these included no analysis and were merely conclusory. Eight did not discuss
the type of electrical stimulation treatment for which the BIO-1000 was
ostensibly prescribed. One referred to a device other than the BIO-1000. And
three tested electrical stimulation treatments in animals.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The MAC identified additional methodological errors in the four remaining
studies that did actually address the BIO-1000's safety and effectiveness in
humans and that could potentially offer credible evidence. All four studies
failed to isolate the effect of concurrent drug therapy. In other words,
they failed to exclude the possibility that other drugs or regimens besides
the BIO-1000 accounted for any patient improvement. Two studies had small
sample sizes, one of only 58 subjects and another with 78 subjects. Two
others had experimental design problems &mdash; one study was not randomized or
double-blind, and the other lacked a proper control group.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In addition, the MAC discounted these four studies because the authors <span CLASS="page_no" data-cite="2012 bl 102107 p 9" data-cite-type="Bloomberg" data-cite-pageno="9" data-primary-citation="">[**9]</span> all
had financial ties to either BioniCare or the BIO-1000's original developer
Murray Electronics. The regulations pertaining to acceptable evidence in the
MPIM explicitly provide that "limited case studies distributed by sponsors
with a financial interest in the outcome[] are not sufficient evidence of
general acceptance by the medical community." MPIM &sect; 13.7.1, Evidence
Supporting LCDs.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  BioniCare asserts that because its studies were independently published,
they were not "distributed by sponsors," and therefore not within this rule.
Given the substantial deference that we owe the Secretary's reasonable
interpretations of her own regulations, however, we cannot conclude that her
actions were unreasonable. <i>See Seminole Rock</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X2N5SO?jcsearch=325%20us%20410&amp;summary=yes#jcite">325 U.S. at 414</a>,
<a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X2N5SO?jcsearch=65%20supreme%20court%201215&amp;summary=yes#jcite">65 S.Ct. 1215</a>. It is a maxim of evidence that a party's interest in a
potential outcome can affect his objectivity, and the MPIM regulation is
clearly directed at ensuring that coverage decisions rest on an objective
and disinterested foundation. The financial interest of those conducting
studies goes to the credibility of the supporting evidence, and this court
has been clear that "absent extraordinary circumstances, we will riot
disturb an [agency]'s credibility determinations." <i>N.L.R.B. v.</i>
<i>Transpersonnel, Inc.</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X6B81U?jcsearch=349%20f%203d%20175&amp;summary=yes#jcite">349 F.3d 175</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X6B81U?jcsearch=349%20f%203d%20175&amp;summary=yes#jcite">184</a> (4th Cir.2003).<a HREF="#fn200" name="fnref_fn200">[fn2]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  While the record is more than sufficient to justify the Secretary's
factual conclusion that BioniCare had not carried its burden of showing that
the BIO-1000 was safe and effective, our analysis is not scientifically
detailed. Nor would such an assessment be permitted. The Supreme Court has
warned time and again that a "technical factual dispute simply underscores
the appropriateness of deferring" to agency decisions. <i>Talk America, Inc. v.</i>
<i>Mich. Bell Tel Co.</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X1FIAHQ003?jcsearch=131%20S.Ct.%202254&amp;summary=yes#jcite">___ U.S. ___</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X1FIAHQ003?jcsearch=131%20supreme%20court%202254&amp;summary=yes#jcite">131 S.Ct. 2254</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X1FIAHQ003?jcsearch=131%20supreme%20court%202254&amp;summary=yes#jcite">2265</a> n. 7, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X1FIAHQ003?jcsearch=180%20l%20ed%202d%2096&amp;summary=yes#jcite">180 L.Ed.2d 96</a>
(2011). Properly
<span CLASS="page_no" data-cite="679 f 3d 307" data-cite-type="PrimaryFederalReporter" data-cite-pageno="307" data-primary-citation="679 F.3d 297">[*307]</span> 
mindful of this fact, BioniCare's brief does not explore the substance of
the science. For "we as a court are confronted with a problem in
administrative law, not in chemistry, biology, medicine, or ecology. It is
the administrative agency which has been called upon to hear and evaluate
testimony . . . relevant to its ultimate question." <i>Envt'l Def. Fund v.</i>
<i>EPA</i><a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X45OFV?jcsearch=489%20f%202d%201247&amp;summary=yes#jcite">489 F.2d 1247</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X45OFV?jcsearch=489%20f%202d%201247&amp;summary=yes#jcite">1252</a> (D.C.Cir.1973). The MAC "has greater expertise and
stands in a better position than this Court to make the technical and policy
judgments necessary to administer the complex regulatory program at issue."
<i>Talk America</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X1FIAHQ003?jcsearch=131%20supreme%20court%202254&amp;summary=yes#jcite">131 S.Ct. at 2265</a> n. 7. The court's role is to perform the
"narrowly defined duty of holding agencies to certain minimal standards of
rationality." <i>Ethyl Corp. v. EPA</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X3O896?jcsearch=541%20f%202d%201&amp;summary=yes#jcite">541 F.2d 1</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X3O896?jcsearch=541%20f%202d%201&amp;summary=yes#jcite">36</a> (D.C.Cir.1976). There can
be little doubt that the Secretary's decisions surpass that threshold and
are supported by "substantial evidence."<a HREF="#fn300" name="fnref_fn300">[fn3]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  V.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Even though the Secretary exercised her statutory discretion to proceed
through adjudication, and her decisions were supported by substantial
evidence, BioniCare nevertheless contends that the Secretary committed a
variety of procedural errors that fatally undermine the MAC decisions. These
claims are rooted in the familiar standards of the APA,
<a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XEGP3C003?jcsearch=5%20U.S.C.%20%20706(2)(A)&amp;summary=yes#jcite">5 U.S.C. &sect; 706</a>(2)(A), which permits a court to "set aside agency actions,
findings, and conclusions found to be . . . arbitrary, capricious, <span CLASS="page_no" data-cite="2012 bl 102107 p 10" data-cite-type="Bloomberg" data-cite-pageno="10" data-primary-citation="">[**10]</span> an abuse
of discretion, or otherwise not in accordance with law." <i><a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XEGP3C003?jcsearch=5%20U.S.C.%20%20706(2)(A)&amp;summary=yes#jcite">Id</a>.</i> This is a
demanding burden for BioniCare to carry. As this court has noted, "[w]hen
the question before the court is whether an agency has properly interpreted
and applied its own regulation, the reviewing court must give the agency's
interpretation 'substantial deference.'" <i>Md. Gen. Hosp., Inc. v. Thompson</i>,
<a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XE7S20?jcsearch=308%20f%203d%20340&amp;summary=yes#jcite">308 F.3d 340</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XE7S20?jcsearch=308%20f%203d%20340&amp;summary=yes#jcite">343</a> (4th Cir.2002) (quoting <i>Th. Jefferson Univ.</i>,
<a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CCJ7?jcsearch=512%20us%20504&amp;summary=yes#jcite">512 U.S. at 512</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CCJ7?jcsearch=114%20supreme%20court%202381&amp;summary=yes#jcite">114 S.Ct. 2381</a>). BioniCare has failed to demonstrate that
the MAC's application of the relevant standards was "plainly erroneous or
inconsistent with" the regulations, <i>Seminole Rock</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X2N5SO?jcsearch=325%20us%20410&amp;summary=yes#jcite">325 U.S. at 414</a>,
<a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X2N5SO?jcsearch=65%20supreme%20court%201215&amp;summary=yes#jcite">65 S.Ct. 1215</a>, and these claims therefore have no merit.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  A.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  BioniCare contends that the Secretary failed to give adequate
consideration to the FDA's clearance of the BIO-1000 for marketing under the
510(k) process. It argues that FDA clearance per se satisfies the
requirement of MPIM <cite>&sect; 13.5.1</cite> that, in order to be considered "reasonable and
necessary," a supplier must establish that a device is safe and effective
and not experimental or investigational. This argument misapprehends,
however, both the separate statutory allocations of interpretive authority
to the Secretary and to the FDA and the relative import of the FDA's 510(k)
clearance.
<span CLASS="page_no" data-cite="679 f 3d 308" data-cite-type="PrimaryFederalReporter" data-cite-pageno="308" data-primary-citation="679 F.3d 297">[*308]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Medicare statute clearly vests the Secretary with the authority to
interpret when a device is "reasonable and necessary," and therefore
eligible for coverage under Part B. The statute contemplates no role for the
FDA, which is charged with applying the standards of the Federal Food, Drug,
and Cosmetic Act, not the Medicare statute. The FDA examines "the labeled
use of a device only," concentrating its review on the safety of a device,
whereas Medicare review "focus[es] on . . . a device under average
conditions of use" to determine whether the device meets the broader
requirement of the Medicare statute that a device be "reasonable and
necessary." <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/1?citation=54%20federal%20register%204307&amp;summary=yes#jcite">54 Fed.Reg. 4307</a>. The Secretary has underscored this difference,
noting that Medicare "contractors make coverage determinations and the FDA
conducts pre-market review of products under different statutory standards
and different delegated authority." <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/1?citation=68%20Fed.Reg.%2055&amp;summary=yes#jcite">68 Fed.Reg. 55</a>,636. The statement
proceeds to make clear that while FDA approval has been adopted as a
prerequisite to Medicare coverage, "FDA approval/clearance alone does not
generally entitle that device to coverage," <i><cite>Id</cite>.</i> While FDA approval may thus
inform the Secretary's decision as to whether a device is "reasonable and
necessary," it cannot tie the Secretary's hands.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  This holds especially true for a device such as the BIO-1000, which was
only cleared by the FDA under the abbreviated 510(k) process. The Secretary
has long noted the significance of the type of clearance a device receives:
"FDA approval . . . will not necessarily lead to a favorable coverage
recommendation, particularly if FDA requirements have been met by means of a
notice issued under <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XUQM9I003?jcsearch=21%20C.F.R.%20Part%20510&amp;summary=yes#jcite">section 510(k)</a>. . . . This is because a <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/1?citation=21%20C.F.R.%20Part%20510&amp;summary=yes#jcite">section 510(k)</a>
notice generally does not involve clinical data showing safety and
effectiveness." <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/1?citation=54%20federal%20register%204307&amp;summary=yes#jcite">54 Fed.Reg. 4307</a>. <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/1?citation=21%20C.F.R.%20Part%20510&amp;summary=yes#jcite">Section 510(k)</a> approval requires only that
a device be "substantially equivalent" to <span CLASS="page_no" data-cite="2012 bl 102107 p 11" data-cite-type="Bloomberg" data-cite-pageno="11" data-primary-citation="">[**11]</span> another device that the FDA has
already approved for marketing, and not that the device have been clinically
examined for safety and effectiveness. The Supreme Court has emphasized this
distinction, noting that a device approved under <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XUQM9I003?jcsearch=21%20C.F.R.%20Part%20510&amp;summary=yes#jcite">510(k)</a> "has never been
formally reviewed . . . for safety or efficacy." <i>Medtronic, Inc. v. Lohr</i>,
<a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CCS2?jcsearch=518%20us%20470&amp;summary=yes#jcite">518 U.S. 470</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CCS2?jcsearch=518%20us%20470&amp;summary=yes#jcite">493</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CCS2?jcsearch=116%20supreme%20court%202240&amp;summary=yes#jcite">116 S.Ct. 2240</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5CCS2?jcsearch=135%20l%20ed%202d%20700&amp;summary=yes#jcite">135 L.Ed.2d 700</a> (1996). In the face of
such consistent statements that FDA approval alone is not enough, and that
510(k) clearance is especially deficient, we cannot say that it was
arbitrary or capricious of the Secretary to require additional proof of the
BIO-1000's safety and effectiveness.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Not only was the BIO-1000 not subject to the more demanding safety review
of the Pre-Market Approval (PMA) process, neither was the TENS device that
served as the predicate for the 510(k) clearance. Because the TENS device
was marketed prior to the 1976 Medical Device Amendments to the Federal
Food, Drug, and Cosmetic Act, its market approval was "grandfathered" rather
than the result of satisfying the requirements of the PMA regime. In short,
the FDA's clearance of the BIO-1000 was based on its equivalence to a device
that was never itself tested for safety and effectiveness. It was therefore
surely reasonable for the Secretary to require evidence in addition to the
mere fact of 510(k) approval to demonstrate the BIO-1000's safety and
effectiveness.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  BioniCare further undercut the already limited significance of the
"substantially equivalent" 510(k) clearance in the Medicare administrative
proceedings by high-lighting differences between the BIO-1000 and the TENS
device. The TENS device seeks to mask pain in nerve tissue by sending high
voltage electrical impulses that interrupt pain signals to the brain. The
BIO-1000, by contrast, operates on
<span CLASS="page_no" data-cite="679 f 3d 309" data-cite-type="PrimaryFederalReporter" data-cite-pageno="309" data-primary-citation="679 F.3d 297">[*309]</span> 
cartilage tissue, using smaller impulses intended to actually improve the
condition of knee joints rather than merely hide the discomfort of the
underlying condition. BioniCare also charges significantly more for the
BIO-1000 than Medicare allows providers to charge for the TENS device. It
was reasonable of the Secretary to conclude that BioniCare's representations
showed that the BIO-1000's "average conditions of use" were quite different
from the uses of the TENS device that served as the predicate to the FDA's
510(k) clearance, and that the FDA's clearance was therefore not adequate
proof of the device's safety and effectiveness.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  BioniCare attempts to claim credit for having initially submitted the
BIO-1000 under the <b>PMA</b> process, under which "[t]he FDA evaluates safety and
effectiveness under the conditions of use set forth on the label." <i>Riegel v.</i>
<i>Medtronic</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X18HPKU003?jcsearch=552%20us%20312&amp;summary=yes#jcite">552 U.S. 312</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X18HPKU003?jcsearch=552%20us%20312&amp;summary=yes#jcite">318</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X18HPKU003?jcsearch=128%20supreme%20court%20999&amp;summary=yes#jcite">128 S.Ct. 999</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X18HPKU003?jcsearch=169%20l%20ed%202d%20892&amp;summary=yes#jcite">169 L.Ed.2d 892</a> (2008). We need
not consider here whether PMA approval would per se satisfy the requirements
of MPIM &sect; 13.5.1, because although the BIO-1000 was submitted for PMA
approval, it only received approval under <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XUQM9I003?jcsearch=21%20C.F.R.%20Part%20510&amp;summary=yes#jcite">section 510(k)</a>. It is immaterial
that the FDA suggested that BioniCare withdraw its request for <b>PMA</b> review
and accept a 510(k) approval "as a result of increasing Congressional
pressure to clear out its backlog." Appellant's Br. <span CLASS="page_no" data-cite="2012 bl 102107 p 12" data-cite-type="Bloomberg" data-cite-pageno="12" data-primary-citation="">[**12]</span> at 46. BioniCare clearly
had the choice to remain in the <b>PMA</b> pipeline. Had it done so, it could at
least now argue to us the greater significance of the more rigorous approval
process. Instead, it opted for the likely more profitable course of getting
the device to market faster. BioniCare chose the speedier and less-demanding
route of 510(k) clearance, and it cannot now claim the legal benefit of a
more exacting review process it ultimately elected not to undertake.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  B.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  BioniCare next asserts that the intermediate review by a qualified
independent contractor (QIC) failed to comply with regulations requiring
input from "a panel of physicians or other appropriate health care
professionals." <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X11MVEI003?jcsearch=42%20C.F.R.%20%20405.968(a)(1)&amp;summary=yes#jcite">42 C.F.R. &sect; 405.968</a>(a)(1). BioniCare is correct that such
input was required, both because "the initial determination involve[d] a
finding on whether an item or service is reasonable and necessary," <i><a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X11MVEI003?jcsearch=42%20C.F.R.%20%20405.968(a)(1)&amp;summary=yes#jcite">id</a>.</i>, and
because the "claim pertains to . . . the provision of items or services by a
physician," <i><cite>id</cite>.</i> <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X11MVEI003?jcsearch=42%20C.F.R.%20%20405.968(c)(3)&amp;summary=yes#jcite">&sect; 405.968(c)(3)</a>. But BioniCare's only evidence that this
requirement was not satisfied is its assertion that the record does not
document compliant participation by a physician. As the district court
properly found, this allegation does not satisfy BioniCare's burden to
substantiate its claim. <i>See Almy</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X1E59HU003?jcsearch=749%20f%20supp%202d%20315&amp;summary=yes#jcite">749 F.Supp.2d at 333</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The regulation imposes no obligation on the QIC to document the physician
review, and BioniCare does not assert that the decisions failed to
adequately explain the scientific or medical basis for the QIC's decision.
"The presumption of regularity supports the official acts of public
officers, and, in the absence of clear evidence to the contrary, courts
presume that they have properly discharged their official duties." <i>United</i>
<i>States v. Chem. Found.</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5BTHK?jcsearch=272%20us%201&amp;summary=yes#jcite">272 U.S. 1</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5BTHK?jcsearch=272%20us%201&amp;summary=yes#jcite">14-15</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5BTHK?jcsearch=47%20supreme%20court%201&amp;summary=yes#jcite">47 S.Ct. 1</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X5BTHK?jcsearch=71%20l%20ed%20131&amp;summary=yes#jcite">71 L.Ed. 131</a> (1926).
Respect for an administrative agency's implementation of its own regulations
requires clear evidence to surmount the hurdle of arbitrary and capricious
review. BioniCare provides no affirmative proof of failure to comply with
the regulation, and we have no reason to displace the "presumption of
regularity [that] attaches to the actions of government agencies." <i>U.S.</i>
<i>Postal Serv. v. Gregory</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XAU35H?jcsearch=534%20us%201&amp;summary=yes#jcite">534 U.S. 1</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XAU35H?jcsearch=534%20us%201&amp;summary=yes#jcite">10</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XAU35H?jcsearch=122%20supreme%20court%20431&amp;summary=yes#jcite">122 S.Ct. 431</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XAU35H?jcsearch=151%20l%20ed%202d%20323&amp;summary=yes#jcite">151 L.Ed.2d 323</a>
(2001).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span CLASS="page_no" data-cite="679 f 3d 310" data-cite-type="PrimaryFederalReporter" data-cite-pageno="310" data-primary-citation="679 F.3d 297">[*310]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  C.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  BioniCare last argues that the Secretary's decisions were arbitrary and
capricious because the MAC decisions at issue here reach a different result
from other decisions at the ALJ and contractor levels of the Medicare review
process that allowed coverage for the BIO-1000. Because some ALJs and
contractors have covered the device and some have not, BioniCare contends
that the Secretary has made inconsistent decisions. As BioniCare admits,
however, "some inconsistency related to the patient-specific nature of the
determination is, perhaps, inevitable." Appellant's Reply Br. at 2.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Moreover, it is undisputed that these lower-level decisions are not
precedential and not binding on the MAC. The Secretary's promulgated
regulations make clear that a decision by a contractor or ALJ is only
binding on the parties to that particular case, and that a decision is not
binding once "a party files a written request for a MAC review that <span CLASS="page_no" data-cite="2012 bl 102107 p 13" data-cite-type="Bloomberg" data-cite-pageno="13" data-primary-citation="">[**13]</span> is
accepted and processed." <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X11MVF4003?jcsearch=42%20cfr%20405%20984&amp;summary=yes#jcite">42 C.F.R. &sect; 405.984</a>. Other circuits have considered
analogous situations, and they all reach the shared conclusion that "[t]here
is no authority for the proposition that a lower component of a government
agency may bind the decision making of the highest level [E]ven if these
cases were found to evince internal inconsistency at a subordinate level,
the [agency] itself would not be acting inconsistently." <i>Community Care</i>
<i>Found, v. Thompson</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X6B5HJ?jcsearch=318%20f%203d%20219&amp;summary=yes#jcite">318 F.3d 219</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X6B5HJ?jcsearch=318%20f%203d%20219&amp;summary=yes#jcite">227</a> (D.C.Cir.2003); <i>see Almy</i>,
<a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X1E59HU003?jcsearch=749%20f%20supp%202d%20315&amp;summary=yes#jcite">749 F.Supp.2d at 326-28</a> (collecting cases).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Moreover, the MAC is explicitly charged with undertaking <i>de novo</i> review,
<i>see</i><a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XEJALO003?jcsearch=42%20U.S.C.%20%201395ff(d)(2)(B)&amp;summary=yes#jcite">42 U.S.C. &sect; 1395ff</a>(d)(2)(B); <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X11MVHK003?jcsearch=42%20C.F.R.%20%20405.1100(d)&amp;summary=yes#jcite">42 C.F.R. &sect; 405.1100</a>(d), which is
incompatible with BioniCare's proffered notion that the MAC is somehow
obligated to defer to the out-comes of prior decisions below. Nowhere does
any policy or regulation suggest that the MAC owes any deference at all to &mdash;
much less is bound by &mdash; decisions of lower reviewing bodies addressing
different disputes between different parties merely because they pertain to
the same device.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  As the Secretary notes, only MAC decisions constitute the final decision
of the Secretary. <i>See <cite>id</cite>.</i> <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X11MVII003?jcsearch=42%20C.F.R.%20%20405.1130&amp;summary=yes#jcite">&sect; 405.1130</a>. BioniCare points to no other MAC
decision specifically finding that the BIO-1000 was "reasonable and
necessary" or "safe and effective." We therefore cannot conclude that "the
agency has failed to explain its departure from prior precedent,"
<i>Bush-Quayle '92 Primary Comm., Inc. v. FEC</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X3KP17?jcsearch=104%20f%203d%20448&amp;summary=yes#jcite">104 F.3d 448</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X3KP17?jcsearch=104%20f%203d%20448&amp;summary=yes#jcite">453</a>
(D.C.Cir.1997), such that the MAC decisions are deprived of deference,
because there simply was no contrary precedent from which the agency
departed. While BioniCare attempts finally to assert that even the MAC
decisions are inconsistent with one another, in every instance in which the
question of whether the device was "reasonable and necessary" was before the
MAC, it applied the same proper standards from the MPFM and reached the same
conclusions about the inadequacy of BioniCare's proffered evidence.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In addition, BioniCare's proposed expansion of what constitutes binding
agency precedent would severely constrict the un-disputed delegated
authority of the Secretary to administer the Medicare system. The Medicare
statute and its accompanying regulations create a "mammoth bureaucracy with
seemingly endless layers of internal review." <i>Homemakers North Shore, Inc.</i>
<i>v. Bowen</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XAFILM?jcsearch=832%20f%202d%20408&amp;summary=yes#jcite">832 F.2d 408</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XAFILM?jcsearch=832%20f%202d%20408&amp;summary=yes#jcite">413</a> (7th Cir.1987). BioniCare seeks to impose
massive resource costs on the Secretary, requiring her to reverse any
decision at a lower level of adjudication either through promulgation of an
NCD or through MAC review lest that lower decision become
<span CLASS="page_no" data-cite="679 f 3d 311" data-cite-type="PrimaryFederalReporter" data-cite-pageno="311" data-primary-citation="679 F.3d 297">[*311]</span> 
precedent that precludes a different considered result in future cases
before the MAC. As the Secretary notes, there were 970 million Medicare Part
B claims in 2008 alone, and the Secretary rarely participates in the lower
level adjudications of those claim determinations. Appellee's Br. at 55 n.
19. Exercising her acknowledged discretion to allocate agency resources, the
Secretary has promulgated regulations limiting <i>sua sponte</i> review to cases
that either "contain[] an error of law material to the outcome of the case
or present[] a broad policy or procedural <span CLASS="page_no" data-cite="2012 bl 102107 p 14" data-cite-type="Bloomberg" data-cite-pageno="14" data-primary-citation="">[**14]</span> issue that may affect the general
public interest." <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X11MVHU003?jcsearch=42%20C.F.R.%20%20405.1110(c)(2)&amp;summary=yes#jcite">42 C.F.R. &sect; 405.1110</a>(c)(2). The Secretary has simply not
seen fit to invoke her final authority in every case in which there is an
argument over whether the evidence adequately supports a finding that a
device was "reasonable and necessary."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In so complex an area as Medicare Part B administration, the courts should
not casually direct the Secretary as to when she must exercise her authority
to make final determinations, especially where, as here, the final
determinations that she has made have been consistent in denying coverage
for the BIO-1000. Congress has delegated broad authority to the Secretary to
determine when a device is reasonable and necessary, as well as broad
authority to select the procedures used for making that determination. The
decisions of local contractors cannot deprive her of that discretion, any
more than the diverse decisions of district courts or courts of appeals
throughout the country could bind the Supreme Court. It was therefore not
arbitrary and capricious of the MAC to make final determinations that may
have been at odds with prior coverage decisions that did not carry the full
imprimatur of the Secretary's authority.<a HREF="#fn400" name="fnref_fn400">[fn4]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  VI.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Our court has previously noted that the Medicare statute is "among the
most completely impenetrable texts within human experience." <i>Rehab. Ass'n of</i>
<i>Va., Inc. v. Kozlowski</i><a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XAC5UK?jcsearch=42%20f%203d%201444&amp;summary=yes#jcite">42 F.3d 1444</a>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XAC5UK?jcsearch=42%20f%203d%201444&amp;summary=yes#jcite">1450</a> (4th Cir.1994). This complexity,
however, in no
<span CLASS="page_no" data-cite="679 f 3d 312" data-cite-type="PrimaryFederalReporter" data-cite-pageno="312" data-primary-citation="679 F.3d 297">[*312]</span> 
way permits courts to abandon their reviewing role, for the absence of
judicial oversight would risk unsupported and unexplained agency decisions.
We have thus reviewed the claims herein with care, and we are satisfied that
the Secretary has proceeded in accordance with law.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  To go further would invite unforeseeable consequences in health care
costs, public resource allocation, and coverage of dubious medical devices.
At the end of the day, we must respect the fact that Congress has chosen to
leave the interpretation of the "reasonable and necessary" requirement of
Medicare Part B to the informed discretion of the Secretary and the
professional panels who exercise her authority. The Secretary has not taken
this responsibility lightly, promulgating voluminous regulations, coverage
manuals, and notice documents explaining the standards that will guide her
determinations. She has created an exhaustive review process ensuring that
claimants will have repeated and extensive opportunities to ensure that
compliant claims are properly reimbursed.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Yet BioniCare urges us to wade into this area with very little to keep us
afloat. It would have us supplant the Secretary's decisions about whether to
adjudicate, how to adjudicate, and even how to decide those adjudications
without a shred of guidance from Congress to secure our decisions. It is the
Secretary, not the courts, who bears the responsibility for the disbursement
of billions of dollars of public money under the Medicare system.
Appropriations are not our forte, and we shall not redirect the Secretary
without a greater showing in law than BioniCare <span CLASS="page_no" data-cite="2012 bl 102107 p 15" data-cite-type="Bloomberg" data-cite-pageno="15" data-primary-citation="">[**15]</span> has made here.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The judgment of the district court is <i>AFFIRMED.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn100" name="fn100">[fn1]</a></span> MPIM <cite>&sect; 13.3</cite>, Individual Claim Determinations, erroneously lists the
chapter number for "Reasonable and Necessary Provisions in LCDs" as "3.5.1."
This appears to be a typo-graphical error; the correct heading for that
subsection is "13.5.1."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn200" name="fn200">[fn2]</a></span> BioniCare seeks to rehabilitate its evidence from this deficiency by
claiming that any bias in the studies is outweighed by the fact that the
articles, are peer-reviewed. The weight to be given peer reviews is again an
evidentiary matter best left to the MAC as finder of fact, and not to a
reviewing court of appeals. Moreover, it is an argument that courts are
particularly ill-equipped to assess. Whether a medical study satisfied the
standards of scientific rigor that BioniCare claims is hardly a matter on
which the normal judicial deference to the Secretary's determinations can be
discarded.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn300" name="fn300">[fn3]</a></span> BioniCare also argues that the Secretary's acceptance of the
BIO-1000's safety and effectiveness is demonstrated by the fact that the
Center for Medicare and Medicaid Services assigned a billing code to the
device under the Healthcare Common Procedure Coding System (HCPCS) and
created a fee schedule for claims for the device. But the fact that the
Secretary may have taken steps to facilitate the administration of the
thousands of claims for the BIO-1000 cannot dictate the ultimate
determination on those claims. The Medicare statute precludes coverage of
items that are "not reasonable and necessary" "[n]otwithstanding any other
provision of this subchapter." <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XEJALA003?jcsearch=42%20U.S.C.%20%201395y(a)(1)(A)&amp;summary=yes#jcite">42 U.S.C. &sect; 1395y</a>(a)(1)(A). Further, the
HCPCS code book contains a disclaimer that "[i]nclusion or exclusion of a
procedure, supply, product or service does not imply any health insurance
coverage or reimbursement policy." <i>Almy</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X1E59HU003?jcsearch=749%20f%20supp%202d%20315&amp;summary=yes#jcite">749 F.Supp.2d at 332</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn400" name="fn400">[fn4]</a></span> BioniCare raises two other issues that do not merit extended
discussion. First, it disputes the application of a local fee schedule in
one of the eight MAC cases under review. The Medicare statute limits
reimbursement for DME to 80 percent of the lesser of either the actual
charge for the item or the fee schedule amount for the item.
<a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XEJAJK003?jcsearch=42%20U.S.C.%20%201395m(a)(1)&amp;summary=yes#jcite">42 U.S.C. &sect; 1395m</a>(a)(1); <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/XDM5GG003?jcsearch=42%20C.F.R.%20%20414.210(a)&amp;summary=yes#jcite">42 C.F.R. &sect; 414.210</a>(a). The ALJ and MAC made
findings that a fee schedule was properly implemented by a local contractor
pursuant to guidance from the Secretary authorizing local "gap-filling" fee
arrangements when no national fee schedule exists. <i>See</i> Medicare Claims
Processing Manual (MCPM) Ch. 23, <cite>&sect; 60.3</cite>. We agree with the district court's
conclusion that the MAC did not act arbitrarily or capriciously in
determining that the lower payment authorized by the fee schedule amount was
the appropriate reimbursement. <i>See Almy</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X1E59HU003?jcsearch=749%20f%20supp%202d%20315&amp;summary=yes#jcite">749 F.Supp.2d at 333-34</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
Second, BioniCare argues that the Secretary erred in rejecting certain
"Advance Beneficiary Notices" (ABN) that purported to shift liability for
device costs to the recipients of the BIO-1000. A supplier can shift the
burden to a beneficiary by providing the beneficiary with advance written
notice that a device will probably not be covered by Medicare. MCPM Ch. 30,
<cite>&sect; 40.1.1</cite>. If the notice merely does "no more than state that Medicare denial
of payment is possible," <i><cite>id</cite>.</i> <cite>&sect; 40.3.6.1</cite>, however, then liability remains
with the supplier. In two decisions at issue here, the Secretary ruled
invalid ABNs that stated that "it is unclear what criteria Medicare will use
when evaluating whether the device was reasonable and medically necessary
for you. Medicare will not pay for a device that it does not deem reasonably
necessary for you." We similarly affirm the district court's conclusion that
the MAC did not act arbitrarily or capriciously in finding that these
generic statements failed to offer a "genuine reason that denial by Medicare
is expected." <i>Almy</i>, <a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X1E59HU003?jcsearch=749%20f%20supp%202d%20315&amp;summary=yes#jcite">749 F.Supp.2d at 335</a> (quoting MCPM Ch. 30 <cite>&sect; 40.3.6.1</cite>).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
</p></div>
<!--BBLS DD 1705386508291-->

</div>
<div class='sideBar printHide clearfix '>
<!-- /Default state -->
<!-- /Display properties -->
<div class='tabsNotepad printHide'>
<div class='tabButtons clearfix'>
<div class='borderTab activeTab' id='buttonTab_general'>
<span>
General Info
</span>
</div>
<div class='borderTab inactiveTab' id='buttonTab_notePad'>
<span>Notepad</span>
</div>
</div>
</div>
<div class='sideBarInner clearfix'>
<div class='sideBarContent bootstrap sidebar ' id='tab_general'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span class='left'>BCite Analysis</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider bciteRenderer clearfix'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1HK8FA003/history">Direct History (4)</a>
</div>
<div class='sidebarItemLabel bold'>
No Negative Direct History
</div>
</div>
<div class='bciteRenderer clearfix sidebarSectionDivider sidebarSubsection'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1HK8FA003/analysis">Case Analysis (13)</a>
</div>
<div class='bciteResult'>
<img class='icon printOnly' src='/images/citation_icons/positive.png'>
<div class='citation icon positive printHide' title='Positive'></div>
<a class='citationAnalysisLabel' href='/bcite/X1HK8FA003/analysis?analysis=BCITE_POSITIVE_GROUP'>
Positive
</a>
<span class='citationNumberLabel'>
13
</span>
</div>
</div>
<div class='sidebarSubsection clearfix analysisLink'>
<div class='sidebarSubhead small'>
<a href="https://www.bloomberglaw.com/help/BCite_Indicators.htm" class="citatorRenderer">Description of BCite Indicators</a>
</div>
</div>

<div id='generalInfo'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span>
General Information
</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Result(s)</div><div class='facetItemLabel'>Judgment Affirmed</div></div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Industries</div><div class='facetItemLabel'>Insurance</div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Related Docket(s)</div><div class='facetItemLabel'><a href="/s/opinion/be4d227409bb86f049aee2c7adec6f3b/document/X1Q6LFAV2HO2">10-02241 (4th Cir.)</a></div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Topic(s)</div><div class='facetItemLabel'>Administrative Law</div><div class='facetItemLabel'>Social Security</div></div>
<div class='sidebarSubsection' id='judges_section'>
<div class='facetItemHeading'>Judge(s)</div>
<div id='judges_section_loader'></div>
</div>
</div>
</div>
</div>
</div>
<div class='sideBarContent clearfix notepad hidden' id='tab_notePad'>
<div id='notepad'>
<div class='notepadInstructions'>
Click anywhere in Notepad to add a note.
</div>
<div class='protoNote note'>
<a class='anchor'></a>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
<div class='ieFloat right'>
<a class='delete'>
Delete
</a>
<div class='toolDivider'>
|
</div>
<a class='edit'>
Edit
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='body'></div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay'></span>
</div>
<div class='ieFloat right'>
<a class='next'>
Next
</a>
</div>
</div>
</div>
<div class='protoNoteEditor note'>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
</div>
<div class='body'>
<textarea class='contents'></textarea>
<div class='toolRow'>
<a class='save'>
Save
</a>
<div class='toolDivider'>
|
</div>
<a class='cancel'>
Cancel
</a>
<div class='clearfix'></div>
</div>
</div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous disabled'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay disabled'></span>
</div>
<div class='ieFloat right'>
<a class='next disabled'>
Next
</a>
</div>
</div>
</div>
<div class='protoConfirmDelete'>
<div class='popupWindowOuter'>
<div class='popupWindowInner'>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>
Delete Note
</h2>
</div>
<div class='popupContent'>
<div class='sectionLabel'>
Are you sure you want to delete this note?
<br>
<br>
<br>
<br>
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right'>
<span>
Delete
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup()'>
<span>
Cancel
</span>
</button>
</div>
</div>
</div>
</div>
</div>

</div>
</div>

</div>
<div class='clearfix'></div>
</div>

<div class='keywordSearch' id='keyword_search'>
<a href="javascript:Blaw__findPrevKeyWord();redrawPrevNextButtons();" id="keyword_search_previous">Previous Keyword</a>
|
<a href="javascript:Blaw__findNextKeyWord();redrawPrevNextButtons();" id="keyword_search_next">Next Keyword</a>
</div>
<div class='pageLoader'></div>
<div class='browserPopupContainer' id='browserPopup'>
<div class='browserTitle'>
<div class='close' onclick='$("#browserPopup").bbTocBrowser(false);'></div>
<h2 class='popup_title'></h2>
</div>
<div class='browserPopupContent popup_content' id='browserPopupContent'></div>
</div>
<div class='maskOverlay' id='ajax_browser_mask'></div>


<div class='clearfix'></div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->
<div class='clientMatterContainer hidden' id='clientMatterContainer'>
<form accept-charset="UTF-8" action="/client_matter/session/create" id="startClientMatterSessionForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id="create_client_matter" name="create_client_matter" type="hidden" value="false" />
<div class='clearfix popupTitle'>
<div class='close' onclick='cancelClientMatterPopup()'></div>
<h2>
Enter a Client Matter
</h2>
</div>
<div class='popUpContent'>
<div class='clientMatterPopupHeader'>
Your firm optionally allows a client matter to be selected while you are using Bloomberg Law.
Please select from a recently used Client Matter or enter a Client Matter manually.
</div>
<div class='error' id='clientMatterLabelErrors' style='display:none'></div>
<div class='error' id='attorneyNumberLabelErrors' style='display:none'></div>
<div class='row sources clearfix'>
<div class='labelHolder'>
<span class='label'>Client Matter</span>
</div>
<div class='inputContainer'>
<input autocomplete="off" class="autocompleteTextField input_auto autocompleteForm" data-context="CLIENT_MATTERS" data-highlight-term="true" data-select-callback="applyClientMatterFromAutocompleteSelection" data-show-no-matches="false" data-url="/autocomplete/lookup" id="client_matter_label" name="client_matter_label" type="text" value="" />
<script type="text/javascript">
//<![CDATA[
jQuery().ready(function ($) { $('#client_matter_label').bbAutocomplete(); });
//]]>
</script>
</div>
</div>
<div class='row clientMatterSuppressionCheckholder' id='clientMatterSuppressionCheckholder'>
<label>
<input id="suppress_client_matter_prompt_enabled" name="suppress_client_matter_prompt_enabled" type="hidden" value="1" />
<input checked="checked" id="suppress_client_matter_prompt" name="suppress_client_matter_prompt" type="checkbox" value="1" />
<label for="suppress_client_matter_prompt">Do not remind me again this session</label>
</label>
</div>
<div class='clientMatterText'>
Please contact your administrator if you have questions about client matter.
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup right' type='submit'>
<span>
Submit
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='cancelClientMatterPopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

<div id='createClientMatterForm' style='display:none'>
<div class='clearfix popupTitle'>
<h2>
Unrecognized Client Matter
</h2>
</div>
<div class='div'>
Client Matter
<span id='new_client_matter_label'>&nbsp;</span>
does not currently exist in Bloomberg Law. Would you like to add this client matter to the system?
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' type='button'>
<span>
Yes
</span>
</button>
<button class='bootstrap skinButton popup cancel right' type='button'>
<span>
No
</span>
</button>
</div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->

<div id='loading_container'></div>
<div class='fixedControls menuHolder printHide' id='bottom_menu_row'>
<div class='menuButton' id='pde_tray_menu'>
<div class='queueImageHolder'></div>
<div class='indicator num_of_pde_tray_items'></div>
</div>
<div class='clearfix'></div>
</div>
<div class='menuItem bottomMenu' id='pde_tray'>
<div class='inner'>
<div class='heading'>
<div class='title'>
Queue
<span class='indicator num_of_pde_tray_items'></span>
<!-- =pde_tray_count_from_session -->
</div>
<div class='bootstrap closeIcon right' id='pde_tray_close_button'></div>
<div class='clearfix'></div>
</div>
<div class='actions hasItems' id='pde_tray_has_items'>
<div class='selection'>
<div class='trayCheckHolder'>
<input id='pde_tray_select_all' type='checkbox'>
</div>
Select All
</div>
<div class='tools'>
<a onclick='javascript:PDETray_default.downloadSelection();'>
Print/Download
</a>
|
<a onclick='javascript:PDETray_default.emailSelection();'>
Email
</a>
|
<a onclick='javascript:PDETray_default.workspaceSelection();'>
+ Workspace
</a>
|
<a onclick='javascript:PDETray_default.deleteSelection();'>
Delete
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='actions noItems' id='pde_tray_no_items'>
<div class='title'>
You have no items in your Queue
</div>
<div class='clearfix'></div>
</div>
<div class='itemsHolder' id='pde_tray_items'></div>
</div>
</div>

<div class='maskOverlay' id='pde_tray_mask'></div>

<script language='javascript'>
var SHOW_AUDIT = false;
var ROOT_PATH = "/";
var RAILS_ROOT = "/";
var CONTEXT_PATH = "/";
var DOC_ROOT_PATH = "/s/opinion/be4d227409bb86f049aee2c7adec6f3b/";
var RESULTS_ROOT_PATH = "/search/results/";
var SELECTED_CONTEXT = "";
var MODULE_PATH;
MODULE_PATH = "/document";
var CRUMB_ID = "be4d227409bb86f049aee2c7adec6f3b";
var BILLING_CONFIGURATION = {"DOCKET":true,"NEWS":false,"LAW":true,"ADVANCED_LEGAL":true,"PATENT":true,"PATENT_ASSIGNMENT":true,"PEOPLE":false,"OPINION":true,"CITATION":false,"BREAKING":true,"DOCKET_REQUESTS":true,"COMPANY_FILINGS_EDGAR":false,"COMPANY_FILINGS_DOCKETS":false,"COMPANY_FILINGS_OTHER":false,"CORP_ACTIONS":true,"ECO_SEARCH":true,"EDGAR_SEARCH":true,"EXAMPLE_DOCUMENTS":true,"CLAUSE_SEARCH":true,"LEG":true,"REG":true,"BOOLEAN":false,"SIMPLE":false,"COMPANY_DOCKETS":true,"TOC_SEARCH":true,"IMMUTABLE_LAW_SEARCH":true};
var CONTEXT_BILLING_POLICY_KEY = "";
var ELITE_ENABLED = false;
var CLIENT_MATTER_PROMPT_ENABLED = false;
var CLIENT_MATTER_ON_LOGIN_ENABLED = false;
var SUPPRESS_CLIENT_MATTER_PROMPT = false;
var clientMatterActive = false;
var currentClientMatter = '';
var currentAttorneyNumber = '';
var clientMatterHaltedForm = null;
var USER_ID = 'un=373038066';
var SESSION_ID = '63166_a5929cc15e1bfd637ed52768bec5d196';
var NTPT_REDIRECTED_EVENT = '';
var NTPT_PGEXTRA = '&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITY0675b7&previousPageId=&previousActivityInstanceId=ENTITY0f8019&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T00:48:01-05:00';
var NTPT_GLBLEXTRA = 'un=373038066&sessionId=63166_a5929cc15e1bfd637ed52768bec5d196&auth=true';
var BROWSER_COMPATIBILITY_WARNING = 'false';
var SHOW_MODAL = false;
var JUG;
$(document).ready(function(){
setTimeout(framework_getPageState,500);
framework_bindGlobalResizeElements();
notepad_onDocumentLoaded();
<!-- /DRQS 24932463 -->
$("#downloadPopupLinkForm a").removeAttr("href");
$('#startClientMatterSessionForm').submit(function() {
  createClientMatterSessionFromForm(this);
  return false;
});

var t = $('.clientMattersTableEl');

jQuery.each(t, function(name, value) {
  try {
    var this_value =  $.trim(String(value.innerHTML));
    var this_final_value = this_value.length > 22 ? this_value.substring(0,9)+"..." : this_value;
    value.innerHTML = this_final_value;
  } catch (e) {}
});

$('#startClientMatterSessionForm .recentlyUsed td').click(function() {
  $('#client_matter_label').val($.trim($(this).attr("title")));
});

});
</script>
<script type='text/javascript'>
DOCUMENT_SHOW_SIDEBAR="true";
DOCUMENT_HAS_SIDEBAR_INFO="true";
DOCUMENT_IS_IFRAME="";
NTPT_PGEXTRA = 'documentSearchType=OPINION&docId=X1HK8FA003&docType=OPINIONS&contentClass=LEGAL&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITY0f8019&previousPageId=&previousActivityInstanceId=ENTITY9e33f0&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T00:47:59-05:00';
FLUID_LAYOUT="false";
FULL_DOC_ID = 'X1HK8FA003';
NOTEPAD_UUID="11082191";
NOTEPAD_DOC_ID="X1HK8FA003";
$('#page_loader').show().spin();
JUDGE_IDS=["1479602","6375207"];
JUDGE_NAMES=null;
</script>

<script src="/javascripts/activity_tracking/ni.js?1376494218" type="text/javascript"></script>
<script src="/javascripts/activity_tracking/tracking.js?1384975732" type="text/javascript"></script>
<div class='footer'>
<div class='footerContent printHide'>
<div class='logoContainer grid eight'>
<div class='copyright'>
&copy; 2014 The Bureau of National Affairs, Inc. All Rights Reserved.
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPR08'); return false;">Terms of Service</a>
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPH08'); return false;">Privacy Policy</a>
</div>
<a class='logo' href='/home'></a>
<div class='version'>
2.
231154
Gem
0.176.7
231497
 - 3.0.20
</div>
<div class='helpContainer'>
<div class='helpDesk'></div>
<a href="/help/BLAWHelpSystem.htm#Contact_Us.htm" class="menuLink">Submit Feedback</a>
 | 
<a href="mailto:blawhelp@bna.com" class="menuLink">blawhelp@bna.com</a>
</div>
</div>
</div>

</div>
</div>
</body>
</html>
